6794356	130	170	atrial flutter, congestive heart failure	MESH:D006333
6794356	293	307	atrial flutter	MESH:D001282
6794356	345	360	cardiac disease	MESH:D006331
6794356	576	600	congenital heart disease	MESH:D006331
6794356	651	672	neurologic depression	MESH:D003866
6794356	674	682	cyanosis	MESH:D003490
6794356	688	706	cardiac arrhythmia	MESH:D001145
6504332	0	32	Phenobarbital-induced dyskinesia	MESH:D004409
6504332	99	120	neurologic impairment	MESH:C537301
6504332	133	143	dyskinesia	MESH:D020820
6504332	216	234	movement disorders	MESH:D009069
6504332	313	323	dyskinesia	MESH:D020820
6504332	415	433	movement disorders	MESH:D009069
6436733	0	30	Acute changes of blood ammonia	MESH:D006402
6293644	400	413	hyperactivity	MESH:D006948
6293644	545	548	GAD
6203632	37	56	cardiac hypertrophy	MESH:D006332
6203632	77	96	cardiac hypertrophy	MESH:D006332
6203632	125	136	Wistar rats	MESH:D011906
6203632	812	824	hypertrophic	MESH:D002312
6203632	1058	1069	hypertrophy	MESH:D006984
6203632	1241	1253	hypertrophic	MESH:D002312
6203632	1330	1342	cardiac mass	MESH:C536030
6203632	1471	1491	cellular hypertrophy	MESH:D006984
6203632	1496	1507	hyperplasia	MESH:D006965
3131282	504	554	hyperplastic changes of the forestomach epithelium	MESH:D001471
3131282	675	693	forestomach tumors	MESH:D009369
3131282	709	732	papilloma and carcinoma	MESH:D010212
3131282	760	769	carcinoma	MESH:D002277
3131282	800	809	carcinoma	MESH:D002277
3131282	1002	1024	epithelial hyperplasia	MESH:D017573
3131282	1026	1032	Tumors	MESH:D009369
3131282	1038	1048	papillomas	MESH:D010212
2917114	552	584	greater cardiovascular stability	MESH:D043171
2917114	680	692	bradycardias	MESH:D001919
2339463	0	25	Cerebral sinus thrombosis	MESH:D012851
2339463	81	92	menorrhagia	MESH:D008595
2339463	140	194	superior sagittal and left transverse sinus thrombosis	MESH:D020225
2339463	259	270	menorrhagia	MESH:D008595
2339463	328	339	menorrhagia	MESH:D008595
2339463	410	432	thromboembolic disease	MESH:D013923
2339463	473	525	epsilon-aminocaproic acid, cerebral sinus thrombosis	MESH:D012851
1545575	0	20	Hemorrhagic cystitis	MESH:D003556
1545575	63	83	Hemorrhagic cystitis	MESH:D003556
1545575	590	610	hemorrhagic cystitis	MESH:D003556
1545575	680	700	hemorrhagic cystitis	MESH:D003556
1545575	839	859	hemorrhagic cystitis	MESH:D003556
1545575	1003	1023	hemorrhagic cystitis	MESH:D003556
1286498	1184	1193	alertness
839274	0	16	Hepatic adenomas	OMIM:142330
839274	21	46	focal nodular hyperplasia	MESH:D020518
839274	126	141	hepatic adenoma	OMIM:142330
839274	159	178	nodular hyperplasia	MESH:D020518
839274	554	591	adenoma and focal nodular hyperplasia	MESH:D020518
591536	9	24	thromboembolism	MESH:D013923
591536	120	136	thrombocytopenia	MESH:D013921
591536	147	162	thromboembolism	MESH:D013923
591536	311	319	ischemia	MESH:D007511
591536	412	428	thrombocytopenia	MESH:D013921
591536	558	603	gastrointestinal and musculoskeletal symptoms	MESH:D009140
591536	622	630	ischemic	MESH:D002545
591536	832	847	thromboembolism	MESH:D013923
591536	852	868	thrombocytopenia	MESH:D013921
20735774	73	92	acute liver failure	MESH:D017114
20735774	173	192	acute liver failure	MESH:D017114
20735774	600	619	acute liver failure	MESH:D017114
20735774	821	840	acute liver failure	MESH:D017114
20735774	1102	1121	acute liver failure	MESH:D017114
20735774	1271	1290	acute liver failure	MESH:D017114
20705401	208	227	psychotic disorders	MESH:D011618
20705401	236	249	schizophrenia	MESH:D012559
20705401	417	430	hyperactivity	MESH:D006948
20705401	741	754	schizophrenia	MESH:D012559
20705401	856	875	psychotic disorders	MESH:D011618
20705401	924	933	psychosis	MESH:D011618
20705401	972	985	schizophrenia	MESH:D012559
20705401	1085	1094	psychosis	MESH:D011618
20705401	1274	1283	psychosis	MESH:D011618
20705401	1501	1510	psychosis	MESH:D011618
20705401	1820	1829	psychosis	MESH:D011618
18657397	347	358	Wistar rats	MESH:D011906
18363626	51	64	pediatric MRI	MESH:C536215
18363626	455	485	pediatric radiological imaging	OMIM:300290
18363626	1500	1511	bradycardia	MESH:D001919
18363626	2028	2041	pediatric MRI	MESH:C536215
16192988	42	45	MAP	MESH:C535477
16192988	204	225	psychiatric disorders	MESH:D005329
16192988	387	396	male CD-1	MESH:D006223
16192988	469	482	hyperactivity	MESH:D006948
16192988	596	599	MAP	MESH:C535477
16192988	1144	1147	MAP	MESH:C535477
16157917	65	98	idiopathic generalized epilepsies	MESH:D004829
16157917	119	152	idiopathic generalized epilepsies	MESH:D004829
16157917	257	259	MJ
16157917	154	157	IGE	MESH:D004829
16157917	240	255	myoclonic jerks	MESH:D009207
16116131	59	70	dyskinesias	MESH:D020820
16116131	74	91	Parkinson disease	MESH:D010300
16116131	158	168	dyskinesia	MESH:D020820
16116131	317	334	Parkinson disease	MESH:D010300
15930398	320	323	BIS
15930398	302	318	bispectral index	OMIM:607447
15930398	2795	2798	BIS
15867025	14	33	perinatal hepatitis	MESH:D006505
15867025	154	173	perinatal hepatitis	MESH:D006505
15867025	429	438	hepatitis	MESH:D006505
15867025	476	485	hepatitis	MESH:D006505
15867025	541	550	hepatitis	MESH:D006505
15867025	597	606	hepatitis	MESH:D006505
15867025	788	797	hepatitis	MESH:D006505
15867025	839	848	Hepatitis	MESH:D006505
15867025	941	950	hepatitis	MESH:D006505
15867025	1151	1160	hepatitis	MESH:D006505
15867025	1709	1728	perinatal hepatitis	MESH:D006505
14975762	164	189	myocardial cell apoptosis	MESH:D009202
14975762	328	344	cardiac myocytes	MESH:D006331
14975762	1083	1102	acute heart failure	MESH:D006333
14736955	70	91	doxorubicin nephrosis	MESH:D009401
14736955	145	156	nephropathy	OMIM:161900
14736955	180	221	glomerular and late-onset tubular lesions	MESH:D007673
14736955	634	663	Glomerular and tubular injury	MESH:D007673
14736955	950	980	glomerular and tubular lesions	MESH:D007673
14736955	1254	1269	tubular lesions	MESH:D001768
14736955	1294	1312	glomerular lesions	MESH:D007673
14736955	1333	1371	animals, glomerular and tubular injury	MESH:D007673
14736955	2036	2049	renal lesions	MESH:D001768
11573852	50	54	AIDS	MESH:D000163
11573852	131	135	AIDS	MESH:D000163
11573852	679	683	AIDS	MESH:D000163
11573852	688	711	cryptococcal meningitis	MESH:D016919
11573852	1096	1100	AIDS	MESH:D000163
9875685	1029	1031	OD	OMIM:165800
9875685	1056	1058	TD	MESH:C536507
9875685	1152	1154	OD	OMIM:165800
9875685	1184	1186	TD	MESH:C536507
9875685	1282	1284	TD	MESH:C536507
9875685	1311	1313	OD	OMIM:165800
9875685	1335	1337	TD	MESH:C536507
9875685	1364	1366	OD	OMIM:165800
9875685	1391	1393	TD	MESH:C536507
9875685	1425	1427	OD	OMIM:165800
9875685	1457	1459	TD	MESH:C536507
9875685	1524	1526	OD	OMIM:165800
9875685	1553	1555	TD	MESH:C536507
9875685	1577	1591	nephrotoxicity
9875685	1596	1598	TD	MESH:C536507
9875685	1731	1733	OD	OMIM:165800
9848575	112	126	cardiomyopathy	MESH:D009202
9848575	724	756	histopathological cardiomyopathy	MESH:D009202
9848575	999	1013	cardiomyopathy	MESH:D009202
9848575	1374	1388	cardiomyopathy	MESH:D009202
9848575	1444	1466	chronic cardiotoxicity	MESH:D002908
9321531	0	33	Posteroventral medial pallidotomy	MESH:D020423
9321531	79	112	Posteroventral medial pallidotomy	MESH:D020423
9321531	995	1020	contralateral dyskinesias	MESH:D020820
9321531	1109	1132	ipsilateral dyskinesias	MESH:D020820
9321531	1217	1305	dyskinesias and the total scores for off-period parkinsonism, contralateral bradykinesia	MESH:D018476
9321531	1396	1419	ipsilateral dyskinesias	MESH:D020820
9321531	1919	1956	dyskinesias and off-period disability	MESH:D020820
9321531	2078	2092	axial symptoms	MESH:C537792
9305828	185	227	during experimental temporal lobe epilepsy	MESH:D004833
9305828	229	232	TLE
9305828	634	637	NPY
9305828	710	713	NPY
9305828	796	817	inner molecular layer	MESH:D007759
9305828	947	955	amygdala
9041081	478	488	myopic PRK
9041081	930	942	control eyes	MESH:D007174
8305357	214	218	AIDS	MESH:D000163
8305357	290	297	sarcoma	MESH:D012509
8305357	415	466	Clinical, biochemical and haematological toxicities	MESH:D056486
8305357	613	620	sarcoma	MESH:D012509
8305357	879	890	neutropenia	MESH:D009503
8012887	54	73	arterial thrombosis	MESH:D002341
8012887	119	145	heparin-induced thrombosis	MESH:D013927
8012887	269	279	thrombosis	MESH:D013927
8012887	426	445	thrombosis syndrome	MESH:D013927
8012887	559	569	thrombosis	MESH:D013927
7651879	208	227	cardiac arrhythmias	MESH:D001145
3015327	47	67	isoniazid neuropathy	MESH:D003929
3015327	84	94	neuropathy	MESH:D003929
2980315	418	457	Frequencies of ventricular fibrillation	MESH:D014693
2819587	30	56	cerebral venous thrombosis	MESH:D019851
2819587	144	175	cerebral deep venous thrombosis	MESH:D020246
2819587	310	323	mental status	MESH:D013226
2819587	570	590	arterial angiography	MESH:D002539
1564236	306	331	myocardial underperfusion	MESH:D009202
1564236	417	426	hyperemic
1564236	602	627	myocardial underperfusion	MESH:D009202
1564236	662	679	coronary stenosis	MESH:D023921
1564236	1176	1206	dipyridamole-induced hyperemia	MESH:D006940
1564236	1451	1460	hyperemia	MESH:D006940
1564236	1692	1701	hyperemia	MESH:D006940
1564236	2053	2070	coronary stenosis	MESH:D023921
1300436	60	71	nephropathy	OMIM:161900
1300436	211	222	nephropathy	OMIM:161900
1300436	314	333	renal insufficiency	MESH:D051437
1300436	1083	1096	Renal failure	MESH:D051437
1300436	1227	1238	nephropathy	OMIM:161900
1141447	49	67	diabetes insipidus	MESH:D003919
1141447	95	113	diabetes insipidus	MESH:D003919
188339	41	53	liver tumors	MESH:D008107
188339	138	150	liver tumors	MESH:D008107
188339	233	245	Liver Tumors	MESH:D008107
188339	475	494	nodular hyperplasia	MESH:D020518
188339	496	503	adenoma	MESH:D000236
188339	505	514	hamartoma	MESH:D006222
188339	520	528	hepatoma	MESH:D006528
188339	642	654	Eight deaths	MESH:D003643
19135948	108	139	sinusoidal obstruction syndrome	MESH:D006504
19135948	144	159	microangiopathy	MESH:D059345
19135948	272	297	graft-versus-host disease	MESH:D006086
19135948	299	303	GVHD
19135948	426	438	antileukemia
19135948	554	578	myelodysplastic syndrome	MESH:D009190
19135948	580	583	MDS	MESH:D054221
19135948	596	618	acute myeloid leukemia	MESH:D015470
19135948	620	623	AML	MESH:D015470
19135948	789	807	grade IV mucositis	MESH:D052016
19135948	839	861	acute grade II-IV GVHD	MESH:D005909
19135948	911	933	chronic extensive GVHD	MESH:D054908
19135948	962	977	microangiopathy	MESH:D059345
19135948	1030	1049	acute renal failure	MESH:D058186
19135948	1137	1168	sinusoidal obstruction syndrome	MESH:D006504
19135948	1170	1173	SOS
12549952	6	19	liver failure	MESH:D017093
12549952	108	121	liver failure	MESH:D017093
12549952	250	265	hyperthyroidism	MESH:D006980
12549952	456	475	acute liver failure	MESH:D017114
12549952	649	661	coagulopathy	MESH:D004211
19370593	135	154	menopausal symptoms	MESH:D008594
19370593	215	237	cardiovascular disease	MESH:D002318
19370593	239	251	osteoporosis	MESH:D010024
19370593	256	264	dementia	MESH:D003704
19370593	453	459	cancer	MESH:D009369
19370593	461	480	gallbladder disease	MESH:D005705
19370593	618	646	Cochrane Menstrual Disorders	MESH:D004412
19370593	850	890	double-blind trials of HT versus placebo	MESH:D050031
19370593	1140	1153	trial quality
19370593	1330	1353	venous thrombo-embolism	MESH:D004617
19370593	1424	1437	breast cancer	MESH:D001943
19370593	1442	1461	gallbladder disease	MESH:D005705
19370593	1527	1550	venous thrombo-embolism	MESH:D004617
19370593	1563	1582	gallbladder disease	MESH:D005705
19370593	1703	1716	breast cancer	MESH:D001943
19370593	1753	1767	benefits of HT	MESH:D050031
19370593	1830	1842	colon cancer	MESH:D003110
19370593	1946	1959	overt disease	MESH:D004194
19370593	2063	2071	dementia	MESH:D003704
19370593	2090	2112	cardiovascular disease	MESH:D002318
19370593	2190	2213	venous thrombo-embolism	MESH:D004617
19370593	2355	2357	HT	MESH:D050031
19370593	2732	2747	chronic disease	MESH:D002908
19370593	2788	2790	HT	MESH:D050031
17019386	29	49	brain around gliomas	MESH:D005910
17019386	158	169	brain edema	MESH:D001929
17019386	196	207	brain tumor	MESH:D001932
17019386	345	348	BBB	OMIM:145410
17019386	624	635	brain tumor	MESH:D001932
17019386	736	752	malignant glioma	MESH:D005910
17019386	786	796	meningioma	MESH:D008579
17019386	1106	1112	glioma	MESH:D005910
17019386	1224	1234	meningioma	MESH:D008579
17019386	1512	1528	BBB near gliomas	OMIM:145410
17019386	1598	1615	peritumoral edema	MESH:D004487
12452237	59	66	myalgia	MESH:D011000
12452237	184	191	myalgia	MESH:D011000
12452237	853	855	LS	MESH:D007888
12452237	1211	1218	myalgia	MESH:D011000
12452237	1590	1597	myalgia	MESH:D011000
12452237	1710	1717	myalgia	MESH:D011000
12452237	2012	2019	myalgia	MESH:D011000
9564988	59	84	acute bacterial sinusitis	MESH:D012852
9564988	237	262	acute bacterial sinusitis	MESH:D012852
9564988	753	775	Haemophilus influenzae	MESH:D008583
9564988	830	851	Moraxella catarrhalis	MESH:D045828
9564988	1298	1309	catarrhalis
9564988	1725	1733	diarrhea	MESH:D003967
9564988	1936	1961	acute bacterial sinusitis	MESH:D012852
7596955	516	541	Twelve healthy volunteers
17965424	47	67	rheumatoid arthritis	MESH:D001172
17965424	118	154	sodium gastrointestinal tolerability	MESH:D005767
17965424	249	283	gastrointestinal (GI) tolerability	MESH:D005767
17965424	351	371	rheumatoid arthritis	MESH:D001172
17965424	373	375	RA	MESH:D001172
17965424	462	464	RA	MESH:D001172
17965424	848	873	thrombotic cardiovascular	MESH:D002318
17965424	1004	1006	SD	MESH:D029461
17965424	1423	1429	oedema	MESH:C536897
17965424	1607	1613	oedema	MESH:C536897
17965424	1682	1687	PGADS
17965424	1913	1929	renovascular AEs	MESH:D006978
17042884	52	55	EPS	MESH:C538012
17042884	112	125	bipolar mania	MESH:D001714
17042884	27	50	extrapyramidal symptoms	MESH:D001480
17042884	176	179	EPS	MESH:C538012
17042884	236	249	bipolar mania	MESH:D001714
17042884	151	174	extrapyramidal symptoms	MESH:D001480
17042884	877	903	anticholinergic drug usage	MESH:D019966
17042884	1200	1203	EPS	MESH:C538012
17042884	1387	1390	EPS	MESH:C538012
17042884	1947	1970	extrapyramidal syndrome	MESH:D001480
17042884	2188	2201	bipolar mania	MESH:D001714
17042884	2220	2223	EPS	MESH:C538012
3961813	106	116	neuropathy	MESH:D003929
3961813	445	455	neuropathy	MESH:D003929
3961813	582	592	neuropathy	MESH:D003929
3961813	743	746	DFP
3961813	1032	1049	myelinated fibers	MESH:D058606
20973483	690	699	catalepsy	MESH:D002375
17511042	54	71	chronic hepatitis	MESH:D006521
17511042	164	181	chronic hepatitis	MESH:D006521
17511042	407	430	psychogenic parasitosis	MESH:D020821
16720068	21	39	malignant syndrome	MESH:D016609
16720068	166	202	psychiatric hospital due to insomnia	MESH:D007319
16720068	425	448	psychomotor retardation	MESH:D011596
16720068	1040	1070	neuroleptic malignant syndrome	MESH:D009459
16720068	1072	1075	NMS	MESH:D009459
16720068	1102	1119	NMS-like symptoms	MESH:D009459
16720068	1518	1521	NMS	MESH:D009459
16596970	646	652	status	MESH:D013226
16586083	190	211	myocardial infarction	MESH:D009203
16586083	238	251	heart failure	MESH:D006333
16586083	464	511	renal, vascular and cardiac prostanoid profiles	MESH:D014652
16586083	1016	1025	NT-proBNP
16586083	1156	1187	serious cardiovascular toxicity	MESH:D056486
16586083	974	1014	N-terminal pro brain natriuretic peptide	MESH:C536656
10539815	56	69	heart failure	MESH:D006333
10539815	159	182	ventricular dysfunction	MESH:D018754
10539815	301	325	congestive heart failure	MESH:D006333
10539815	327	330	CHF
10539815	351	375	decreased renal function	OMIM:608852
10539815	578	581	CHF
10539815	695	723	Left Ventricular Dysfunction	MESH:D018487
10539815	820	823	CHF
10539815	999	1023	Decreased renal function	OMIM:608852
10539815	2435	2451	renal impairment	MESH:C536274
10539815	2721	2724	CHF
10539815	2827	2843	renal impairment	MESH:C536274
10539815	2865	2868	CHF
9022662	0	38	Pemoline induced acute choreoathetosis	MESH:D020803
9022662	210	236	attention deficit disorder	MESH:D001289
9022662	312	336	acute movement disorders	MESH:D009069
9022662	700	716	deficit disorder	MESH:D001289
9022662	918	942	prior movement disorders	MESH:D009069
9022662	978	996	movement disorders	MESH:D009069
9022662	1204	1219	choreoathetosis	MESH:C537181
9022662	1367	1404	Pemoline associated movement disorder	MESH:D009069
8677458	78	98	hemorrhagic cystitis	MESH:D003556
8677458	100	120	Hemorrhagic cystitis	MESH:D003556
6323692	31	45	hyperammonemia	MESH:D022124
6323692	294	308	hyperammonemia	MESH:D022124
6323692	446	459	liver disease	MESH:D008107
6323692	1113	1136	muscular incoordination	MESH:D001259
6323692	1287	1301	hyperammonemia	MESH:D022124
20195852	8	19	nephropathy	OMIM:161900
20195852	88	107	cardiac angiography	MESH:D006331
20195852	192	203	nephropathy	OMIM:161900
20195852	205	208	CIN
20195852	409	428	cardiac angiography	MESH:D006331
20195852	518	520	CM
20195852	502	516	contrast media	MESH:D005119
20195852	1074	1087	renal failure	MESH:D051437
20195852	1111	1162	Failure of kidney function, Loss of kidney function	OMIM:610262
20195852	1228	1231	CIN
20195852	1301	1304	CIN
20195852	1389	1401	renal injury	MESH:D058186
20195852	1457	1469	renal injury	MESH:D058186
20195852	1506	1509	CIN
20195852	1771	1774	CIN
20195852	1791	1816	congenital heart diseases	MESH:D006331
18997632	10	33	ventricular tachycardia	MESH:D017180
18997632	468	483	cardiac disease	MESH:D006331
18997632	487	497	arrhythmia	MESH:D001145
18997632	551	574	ventricular tachycardia	MESH:D017180
18997632	742	765	ventricular arrhythmias	MESH:D001145
15565293	95	105	neuropathy	MESH:D003929
15565293	161	180	axonal degeneration	MESH:D009410
15565293	209	219	neuropathy	MESH:D003929
15565293	256	259	OCT
15565293	226	254	optical coherence tomography	MESH:D009901
15565293	323	335	tuberculosis	MESH:D014376
15565293	386	396	neuropathy	MESH:D003929
15565293	505	515	neuropathy	MESH:D003929
15565293	680	690	neuropathy	MESH:D003929
15565293	822	842	acuity, color vision	MESH:D003117
15565293	1330	1340	neuropathy	MESH:D003929
15565293	1527	1542	visual deficits	MESH:D012640
15565293	1578	1593	visual deficits	MESH:D012640
15565293	1909	1924	visual deficits	MESH:D012640
15565293	2099	2109	neuropathy	MESH:D003929
15565293	2514	2524	neuropathy	MESH:D003929
15565293	2596	2612	renal impairment	MESH:C536274
15266215	171	180	arthritis	MESH:D001168
15266215	505	519	osteoarthritis	MESH:D010003
15266215	524	544	rheumatoid arthritis	MESH:D001172
15266215	660	699	cerebrovascular and peripheral vascular	MESH:D016491
15266215	913	927	osteoarthritis	MESH:D010003
15266215	932	952	rheumatoid arthritis	MESH:D001172
15266215	1882	1896	osteoarthritis	MESH:D010003
15266215	1901	1921	rheumatoid arthritis	MESH:D001172
14742097	80	105	female sexual dysfunction	MESH:D012735
14742097	270	288	beneficial effects	MESH:D007088
14742097	325	343	sexual dysfunction	MESH:D012735
11890511	0	20	Erectile dysfunction	MESH:D007172
11890511	697	717	erectile dysfunction	MESH:D007172
11890511	760	780	erectile dysfunction	MESH:D007172
9270571	217	236	Parkinson's disease	MESH:D010300
9270571	238	240	PD	OMIM:168600
9270571	882	893	dyskinesias	MESH:D020820
9270571	924	942	dyskinetic effects	MESH:D002547
9270571	1560	1571	dyskinesias	MESH:D020820
9270571	1860	1868	levodopa
9270571	2073	2075	PD	OMIM:168600
6415512	586	607	ceroid lipofuscinosis	MESH:D009472
1728915	22	41	cardiac dysfunction	MESH:D006331
1728915	111	128	sinus bradycardia	OMIM:608567
1728915	133	155	atrioventricular block	MESH:D054537
1728915	338	357	cardiac dysfunction	MESH:D006331
1728915	395	413	sinus tachycardias	MESH:D013616
1728915	572	588	bradyarrhythmias	MESH:D001919
1728915	592	625	atrioventricular conduction delay	MESH:D054537
1728915	835	850	latter syndrome	MESH:D013577
20558148	119	128	catalepsy	MESH:D002375
20558148	877	886	catalepsy	MESH:D002375
20558148	1595	1604	catalepsy	MESH:D002375
19940105	282	301	Parkinson's disease	MESH:D010300
19940105	303	305	PD	OMIM:168600
19940105	395	408	basal ganglia	MESH:D001480
19940105	1015	1017	PD	OMIM:168600
19940105	1458	1475	motor dysfunction	MESH:C536988
19923525	212	233	cognitive dysfunction	MESH:D003072
19923525	2389	2400	hypotension	MESH:D007022
19058474	0	22	Fatal haemopericardium	MESH:D034062
19058474	27	55	gastrointestinal haemorrhage	MESH:D005767
18808529	81	98	myocardial injury	MESH:D009202
18808529	139	156	myocardial damage	MESH:D001925
18808529	222	242	coronary hypotension	MESH:D007022
18808529	247	271	myocardial hyperactivity	MESH:D009202
18808529	799	802	DGC
18808529	557	588	dystrophin-glycoprotein complex	MESH:D013915
18808529	856	859	DGC
18808529	1557	1560	DGC
18808529	1665	1681	ischaemic injury	MESH:D014947
18808529	1749	1777	sarcolemma of cardiomyocytes
18674790	634	637	HFD
18674790	654	661	obesity	MESH:D009765
18674790	619	632	high fat diet	MESH:D005218
18674790	873	892	cardiac dysfunction	MESH:D006331
18674790	989	1014	renal or hepatic toxicity	MESH:D056486
18674790	1162	1164	ND	MESH:C537849
18674790	1170	1172	OB	OMIM:164160
18674790	1145	1160	normal diet-fed	MESH:C537354
18674790	1353	1371	cardiac peroxisome	MESH:D018901
18674790	1530	1532	ND	MESH:C537849
18674790	1573	1575	OB	OMIM:164160
18674790	1701	1704	ADP
18674790	1745	1777	Decreased cardiac erythropoietin	MESH:D012021
18441470	0	31	Complete atrioventricular block	MESH:D054537
18441470	68	84	node dysfunction	MESH:D012804
18441470	220	222	AV	MESH:D054537
18441470	235	251	syncopal attacks	MESH:D013575
18441470	316	338	pacemaker implantation	MESH:D057873
18441470	202	218	atrioventricular	MESH:D054537
17366349	0	30	Neuroleptic malignant syndrome	MESH:D009459
17366349	86	116	Neuroleptic malignant syndrome	MESH:D009459
17366349	118	121	NMS	MESH:D009459
17366349	181	199	movement disorders	MESH:D009069
17366349	223	253	neuroleptic malignant syndrome	MESH:D009459
17366349	255	258	NMS	MESH:D009459
17366349	371	374	NMS	MESH:D009459
17366349	495	508	schizophrenia	MESH:D012559
17366349	545	548	NMS	MESH:D009459
17366349	687	690	NMS	MESH:D009459
16584858	94	115	myocardial infarction	MESH:D009203
16584858	207	223	Mangifera indica
16584858	279	300	myocardial infarction	MESH:D009203
16584858	459	476	myocardial damage	MESH:D001925
16584858	831	839	ischemic	MESH:D002545
16584858	1720	1734	cardiac damage	MESH:D001925
16563323	585	597	MEASUREMENTS
16563323	804	813	myoclonus	MESH:D009207
16428827	301	320	Alzheimer's disease	MESH:D000544
16428827	322	324	AD	MESH:D000544
15985056	244	255	pharyngitis	MESH:D010612
11271907	6	30	haemorrhagic myocarditis	MESH:D009205
11271907	70	94	Haemorrhagic myocarditis	MESH:D009205
9799166	91	102	hemorrhagic	MESH:D006470
9672273	14	27	breast cancer	MESH:D001943
9672273	226	239	breast cancer	MESH:D001943
9672273	301	319	endometrial cancer	MESH:D016889
9672273	553	566	breast cancer	MESH:D001943
9672273	585	597	hysterectomy
9672273	1065	1078	breast cancer	MESH:D001943
9672273	1274	1287	breast cancer	MESH:D001943
9672273	1336	1349	breast cancer	MESH:D001943
9672273	1377	1390	breast-cancer	MESH:D001943
9672273	1507	1520	breast cancer	MESH:D001943
9672273	1695	1708	breast cancer	MESH:D001943
9672273	1869	1890	hypertriglyceridaemia
9672273	2032	2045	breast cancer	MESH:D001943
9672273	2230	2243	breast cancer	MESH:D001943
8854309	66	74	paranoia	MESH:D010259
8854309	76	100	Cocaine-induced paranoia	MESH:D010259
8854309	102	105	CIP
8854309	150	169	idiopathic paranoia	MESH:D010259
8854309	225	258	Measures of pupillary oscillation	MESH:D011681
6674249	48	56	myopathy	MESH:D009135
6674249	127	135	myopathy	MESH:D009135
6674249	224	248	subarachnoid haemorrhage	MESH:D013345
6674249	250	253	SAH	MESH:D013345
6150641	107	136	gastric hypersecretory states	MESH:D013272
6150641	385	411	Zollinger-Ellison syndrome	MESH:D015043
6150641	429	450	systemic mastocytosis	MESH:D034721
6150641	473	498	idiopathic hypersecretion	MESH:D006966
6150641	1293	1324	hepatic or hematologic toxicity	MESH:D056486
6150641	1584	1613	gastric hypersecretory states	MESH:D013272
3670965	41	54	Reye syndrome	MESH:D012202
3670965	265	278	Reye syndrome	MESH:D012202
3670965	489	502	Reye syndrome	MESH:D012202
3670965	558	571	Reye syndrome	MESH:D012202
3670965	847	860	Reye syndrome	MESH:D012202
3670965	1177	1190	Reye syndrome	MESH:D012202
3670965	1216	1233	Australia despite
2826064	29	40	hypokalemia	MESH:D007008
2826064	153	164	hypokalemia	MESH:D007008
2826064	310	321	hypokalemia	MESH:D007008
2826064	1071	1082	hypokalemia	MESH:D007008
1535072	497	516	compulsive disorder	MESH:D003193
1535072	518	534	trichotillomania	MESH:D014256
1535072	536	543	anxiety	MESH:D001008
1504402	52	82	dilevalol-associated hepatitis	MESH:D006505
19917396	11	33	myocardial hypertrophy	MESH:D006984
19917396	61	87	pediatric heart transplant	MESH:C536215
19917396	236	252	cardiac toxicity	MESH:D056486
19917396	283	305	myocardial hypertrophy	MESH:D006984
19917396	613	631	interstitial edema	MESH:D004487
19917396	641	663	myocardial hypertrophy	MESH:D006984
19917396	826	859	Myocardial hypertrophy completely	MESH:D006984
19917396	978	995	myocardial biopsy	MESH:D009202
19917396	1050	1072	myocardial hypertrophy	MESH:D006984
19917396	1197	1216	cardiac involvement	MESH:D006331
19234905	0	36	Comparison of unilateral pallidotomy	MESH:D006261
19234905	41	64	subthalamotomy findings	MESH:D009461
19234905	88	107	Parkinson's disease	MESH:D010300
19234905	187	222	stereotactic unilateral pallidotomy	MESH:D006261
19234905	227	241	subthalamotomy
19234905	265	284	Parkinson's disease	MESH:D010300
19234905	286	288	PD	OMIM:168600
19234905	598	609	dyskinesias	MESH:D020820
18541230	218	227	nephrosis	MESH:D009401
18541230	269	287	nephrotic syndrome	MESH:D009404
18541230	528	555	hematological abnormalities	MESH:D006402
18541230	591	608	renal dysfunction	MESH:C535382
18541230	613	627	hyperlipidemia	MESH:D006949
18541230	977	1001	renal tubular epithelial	OMIM:267430
18541230	1231	1249	nephrotic syndrome	MESH:D009404
18541230	1324	1342	nephrotic syndrome	MESH:D009404
18177388	20	63	left ventricular apical ballooning syndrome	MESH:D054549
18177388	73	97	Takotsubo cardiomyopathy	MESH:D054549
18177388	166	204	ventricular apical ballooning syndrome	MESH:D054549
18177388	248	262	cardiomyopathy	MESH:D009202
18177388	681	700	ballooning syndrome	MESH:D054549
17490864	168	181	schizophrenia	MESH:D012559
17490864	203	228	neurodevelopmental stress	MESH:C531680
17490864	327	340	overt disease	MESH:D004194
17490790	164	183	Parkinson's disease	MESH:D010300
17490790	267	278	neuron loss	MESH:D016388
16047871	17	44	leukocytoclastic vasculitis	MESH:C535509
16047871	142	169	Leukocytoclastic vasculitis	MESH:C535509
16047871	206	223	vessel vasculitis	MESH:D014657
16047871	171	173	LV
16047871	523	540	Cutaneous lesions	MESH:C537797
15673851	162	194	interval of spinal cord ischemia	MESH:D020760
15673851	422	442	Spinal cord ischemia	MESH:D020760
15673851	1625	1645	spinal cord ischemia	MESH:D020760
15673851	1650	1654	NMDA	MESH:D060426
11185967	710	742	alcohol-related seizure disorder	MESH:D019973
11099450	201	223	unilateral pallidotomy	MESH:D006261
11099450	256	284	levodopa-induced dyskinesias	MESH:D004409
11099450	286	289	LID
11099450	652	655	LID
11099450	753	767	ventral lesion	MESH:D006555
11099450	947	1005	volumes of the total lesion cylinder and the dorsal lesion	MESH:D001768
11099450	1051	1090	dyskinesias or parkinsonian 'off' signs	MESH:D020734
11099450	1201	1204	LID
11099450	1239	1260	ventral lesion volume	MESH:D006555
11099450	1266	1277	dyskinesias	MESH:D020820
11099450	1445	1456	dyskinesias	MESH:D020820
11099450	1595	1598	LID
11099450	1743	1754	dyskinesias	MESH:D020820
11027904	539	541	CP	MESH:D002547
11027904	525	537	cold-pressor	MESH:D003139
11027904	957	974	MM opioid abusers	MESH:D009293
10193809	104	129	renal tubular dysfunction	MESH:D005198
10193809	357	368	proteinuria	MESH:D011507
10193809	1374	1392	lysosomal turnover	MESH:D016464
9214597	118	134	pituitary tumors	MESH:D010911
9214597	147	171	estrogen-initiated tumor	MESH:D007319
9214597	256	270	animal cancers	MESH:D009369
9214597	283	288	tumor	MESH:D009369
9214597	367	372	tumor	MESH:D009369
9214597	503	508	tumor	MESH:D009369
9214597	2030	2035	tumor	MESH:D009369
7604176	0	31	Pravastatin-associated myopathy	MESH:D009135
7604176	61	88	acute inflammatory myopathy	MESH:D009220
7604176	266	305	non-insulin-dependent diabetes mellitus	MESH:D003924
7604176	370	390	hypercholesterolemia	MESH:D006937
7604176	419	427	myopathy	MESH:D009135
7604176	532	546	hypothyroidism	MESH:D007037
7604176	572	594	autoimmune thyroiditis	MESH:D013967
7604176	672	706	endomysial inflammatory infiltrate	MESH:C535944
7604176	805	819	toxic myopathy	MESH:D056486
7604176	821	852	pravastatin-associated myopathy	MESH:D009135
7282516	52	78	doxorubicin cardiomyopathy	MESH:D009202
7282516	84	98	cardiomyopathy	MESH:D009202
7282516	100	102	CM
7282516	279	297	myocardial disease	MESH:D009202
7072798	6	21	aplastic anemia	MESH:D000741
7072798	114	129	aplastic anemia	MESH:D000741
7072798	168	176	cataract	MESH:D002386
7072798	330	345	aplastic anemia	MESH:D000741
7072798	448	463	aplastic anemia	MESH:D000741
7072798	570	587	marrow hypoplasia	MESH:C535603
3769769	193	210	sinus bradycardia	OMIM:608567
3769769	274	295	anticholinergic drugs	MESH:D019966
3708922	0	40	Experimental cyclosporine nephrotoxicity	MESH:D009374
3708922	184	198	renal toxicity	MESH:D056486
3708922	680	708	increased CSA nephrotoxicity	MESH:D003057
3708922	720	734	nephrotoxicity
2722224	0	35	Hydrocortisone-induced hypertension	MESH:D046110
2722224	1028	1031	SED	MESH:C535788
2722224	1722	1736	hydrocortisone
2722224	1803	1825	increased blood volume	MESH:D006402
1636026	119	138	acute renal failure	MESH:D058186
1636026	1109	1123	renal function	OMIM:608852
1610717	804	817	hyperactivity	MESH:D006948
1610717	819	835	hypersensitivity	MESH:D006967
783197	83	106	coronary artery disease	MESH:D003324
783197	175	188	heart failure	MESH:D006333
783197	323	346	coronary artery disease	MESH:D003324
783197	535	566	chronic coronary artery disease	MESH:D003324
783197	584	608	congestive heart failure	MESH:D006333
783197	815	854	Left ventricular end-diastolic pressure	MESH:D018487
783197	859	896	left ventricular end-diastolic volume	MESH:D018487
783197	1112	1149	left ventricular end-diastolic volume	MESH:D018487
783197	1775	1798	coronary artery disease	MESH:D003324
783197	1848	1885	left ventricular end-diastolic volume	MESH:D018487
9545159	171	206	gastrointestinal motility disorders	MESH:D015835
9545159	262	282	sudden cardiac death	MESH:D016757
9545159	508	540	gastroesophageal reflux disorder	MESH:D005764
8643973	68	91	advanced ovarian cancer	MESH:D010051
8643973	319	342	advanced ovarian cancer	MESH:D010051
8643973	998	1008	leukopenia	MESH:D007970
8643973	1010	1026	granulocytopenia	MESH:D000380
8643973	1032	1048	thrombocytopenia	MESH:D013921
10743694	830	834	IDDM	MESH:D003922
10743694	861	891	gastrointestinal (GI) toxicity	MESH:D056486
10743694	901	915	cardiomyopathy	MESH:D009202
10743694	970	974	IDDM	MESH:D003922
10743694	1080	1084	PTLD
10743694	1091	1105	cardiomyopathy	MESH:D009202
10743694	1111	1127	hemolytic anemia	MESH:D000743
10743694	1038	1078	post-transplant lmphoproliferate disease	MESH:C536144
3535719	1003	1045	netilmicin and piperacillin- vs tobramycin	MESH:D006086
3535719	1122	1159	aminoglycoside-associated ototoxicity	OMIM:580000
17285209	57	82	angioedema of the stomach	MESH:D000799
17285209	932	942	angioedema	MESH:D000799
17285209	1240	1296	angiotensin receptor blocker (ARB) intestinal angioedema	OMIM:611809
15858223	398	448	VPA-associated oxidative stress and hepatotoxicity	MESH:D054549
15858223	1342	1350	necrosis	MESH:D009336
15858223	1709	1717	necrosis	MESH:D009336
15811908	0	16	Pheochromocytoma	MESH:D010673
15811908	95	111	pheochromocytoma	MESH:D010673
15811908	212	266	acute hypertension with severe headache and vomiting 2	MESH:D014839
15811908	573	589	pheochromocytoma	MESH:D010673
15811908	628	644	pheochromocytoma	MESH:D010673
15811908	1048	1064	pheochromocytoma	MESH:D010673
15764424	102	114	hyperkinesia	MESH:D006948
15764424	251	280	psychiatric emergency service	MESH:D004630
15764424	333	342	psychosis	MESH:D011618
15764424	569	595	global hyperkinesia rating	MESH:D006948
15764424	624	643	global hyperkinesia	MESH:D006948
12101159	8	25	asystolic cardiac	MESH:D006323
12101159	944	958	cardiac arrest	MESH:D006323
6699841	0	24	Renal papillary necrosis	MESH:D007681
6699841	65	85	rheumatoid arthritis	MESH:D001172
6699841	202	226	renal papillary necrosis	MESH:D007681
6699841	228	231	RPN
6699841	592	606	renal toxicity	MESH:D056486
6127992	117	140	ischaemic heart disease	MESH:D006331
6127992	160	175	cardiac failure	MESH:D006333
6127992	193	204	bradycardia	MESH:D001919
6115999	778	804	impaired glucose tolerance	MESH:D044882
6115999	910	918	dyspnoea
6115999	959	974	corneal disease	MESH:D003316
18086064	334	351	cardiac morbidity	MESH:D009767
18086064	746	767	myocardial infarction	MESH:D009203
18086064	811	831	myocardial ischaemia	MESH:D009202
12739036	63	91	systemic lupus erythematosus	MESH:D008180
12739036	193	201	myopathy	MESH:D009135
12739036	243	271	systemic lupus erythematosus	MESH:D008180
12739036	273	276	SLE	MESH:D008180
12739036	440	450	arthralgia	MESH:D018771
12739036	529	537	Myositis	MESH:D009220
12739036	650	679	progressive muscular weakness	MESH:D018908
12739036	684	700	muscular atrophy	MESH:D009133
12739036	841	849	myositis	MESH:D009220
12739036	927	939	polymyositis	MESH:D017285
12739036	943	957	toxic myopathy	MESH:D056486
12739036	994	1002	myopathy	MESH:D009135
12739036	1183	1186	SLE	MESH:D008180
12093990	43	61	adenovirus disease	MESH:D000257
12093990	220	238	adenovirus disease	MESH:D000257
12093990	490	508	adenovirus disease	MESH:D000257
12093990	672	690	adenovirus disease	MESH:D000257
12093990	1021	1058	respiratory syncytial virus infection	MESH:D018357
12093990	1111	1120	hepatitis	MESH:D006505
12093990	1166	1186	choice for infection	MESH:D007239
12093990	1192	1209	hemorrhagic fever	MESH:D006480
12093990	1294	1300	anemia	MESH:D000740
12093990	1333	1353	adenovirus infection	MESH:D000257
12093990	1522	1540	adenovirus disease	MESH:D000257
12093990	1745	1763	adenovirus disease	MESH:D000257
12093990	1799	1819	hemorrhagic cystitis	MESH:D003556
12093990	1964	1984	disseminated disease	MESH:D009103
12093990	2021	2041	adenovirus pneumonia	MESH:D000257
12093990	2082	2099	DiGeorge syndrome	MESH:D004062
12093990	2386	2406	hemorrhagic cystitis	MESH:D003556
12093990	2444	2464	adenovirus pneumonia	MESH:D000257
12093990	2499	2517	adenovirus disease	MESH:D000257
12093990	2629	2642	renal failure	MESH:D051437
12093990	2647	2658	neutropenia	MESH:D009503
12093990	2787	2805	adenovirus disease	MESH:D000257
12093990	2989	3007	adenovirus disease	MESH:D000257
12093990	3224	3242	adenovirus disease	MESH:D000257
12093990	3372	3390	adenovirus disease	MESH:D000257
12093990	3573	3593	adenovirus infection	MESH:D000257
12093990	3655	3673	adenovirus disease	MESH:D000257
3962737	115	131	tachyarrhythmias	MESH:D013610
3962737	230	251	cholestatic hepatitis	MESH:D041781
3962737	404	418	hepatic injury	MESH:D006505
3962737	492	511	alcoholic hepatitis	MESH:D006519
3962737	513	534	cholestatic hepatitis	MESH:D041781
3962737	725	759	cholestatic injury or hepatomegaly	MESH:D006529
2716967	1378	1393	cross-tolerance	MESH:C537866
2716967	1463	1487	antagonism and tolerance
2716967	1601	1616	cross-tolerance	MESH:C537866
19642243	6	19	renal failure	MESH:D051437
19642243	37	41	AIDS	MESH:D000163
19642243	103	116	osteomyelitis	MESH:D010019
19642243	118	131	Renal failure	MESH:D051437
19642243	342	358	Fanconi syndrome	MESH:D005198
19642243	363	382	renal insufficiency	MESH:D051437
19642243	603	616	renal failure	MESH:D051437
17682013	8	27	leukoencephalopathy	MESH:D056784
17682013	110	129	leukoencephalopathy	MESH:D056784
17682013	289	298	leukaemia
17682013	785	810	toxic leukoencephalopathy	MESH:D056486
17682013	1010	1030	hyperintense lesions	MESH:D001768
17682013	1397	1414	ADC abnormalities	MESH:D002869
17682013	1516	1536	matter abnormalities	MESH:D056784
17682013	1596	1615	leukoencephalopathy	MESH:D056784
17682013	1737	1753	cytotoxic oedema	MESH:D001929
16629641	29	35	anemia	MESH:D000740
16629641	62	71	hepatitis	MESH:D006505
16629641	81	98	Chronic infection	MESH:D007239
16629641	104	121	hepatitis C virus	MESH:D006526
16629641	144	179	cirrhosis, hepatocellular carcinoma	MESH:D006528
16629641	123	126	HCV	MESH:D006526
16629641	241	244	HCV	MESH:D006526
16629641	475	491	hemolytic anemia	MESH:D000743
16629641	568	577	hemolysis	MESH:D006461
16629641	588	594	anemia	MESH:D000740
16629641	631	634	HCV	MESH:D006526
16629641	690	714	cardiovascular disorders	MESH:D002318
16629641	728	734	anemia	MESH:D000740
16629641	866	893	ribavirin-associated anemia	MESH:D000740
16629641	1079	1106	ribavirin-associated anemia	MESH:D000740
16629641	1293	1309	hemolytic anemia	MESH:D000743
16629641	1327	1344	chronic hepatitis	MESH:D006521
16006300	175	188	hypercalcemia	MESH:D006934
16006300	244	264	milk-alkali syndrome	MESH:D006934
16006300	358	371	hypercalcemia	MESH:D006934
16006300	453	473	milk-alkali syndrome	MESH:D006934
16006300	509	528	renal insufficiency	MESH:D051437
16006300	539	558	metabolic alkalosis	MESH:D000471
16006300	663	679	malignant lesion	MESH:D001768
16006300	910	922	hypocalcemia	MESH:D006996
16006300	1187	1207	milk-alkali syndrome	MESH:D006934
16006300	1287	1307	Milk-alkali syndrome	MESH:D006934
16006300	1333	1358	unexplained hypercalcemia	MESH:D006934
16006300	1631	1643	hypocalcemia	MESH:D006996
16006300	1679	1692	hypercalcemia	MESH:D006934
11705128	44	60	hemolytic anemia	MESH:D000743
11705128	81	90	hepatitis	MESH:D006505
11705128	354	371	chronic hepatitis	MESH:D006521
11705128	375	378	CHC
11705128	477	493	hemolytic anemia	MESH:D000743
11705128	495	499	RIHA
11705128	618	621	CHC
6540303	55	70	pinealectomized
6540303	215	224	catatonia	MESH:D002389
6540303	375	384	catatonia	MESH:D002389
6540303	386	389	DOC
6540303	1341	1350	catatonia	MESH:D002389
3057041	156	173	allergic rhinitis	OMIM:607154
3057041	326	343	allergic rhinitis	OMIM:607154
3057041	554	571	allergic rhinitis	OMIM:607154
3057041	2201	2218	allergic rhinitis	OMIM:607154
625456	57	77	acute hypercalcaemia	MESH:D000208
625456	99	114	nephrolithiasis	MESH:D053040
7910951	224	239	muscle weakness	MESH:D018908
7910951	365	396	acute respiratory insufficiency	MESH:D012131
7910951	463	471	ND-NMBAs	MESH:C537849
7910951	618	626	acidosis	MESH:D000138
7910951	1118	1125	ND-NMBA	MESH:C537849
7910951	1176	1195	Hepatic dysfunction	MESH:D006505
7910951	1200	1208	acidosis	MESH:D000138
7752389	25	46	bladder hyperactivity	MESH:D006948
7752389	734	753	intra-arterial PGE2	MESH:D059413
7752389	885	904	intra-arterial PGE2	MESH:D059413
7752389	1038	1057	intra-arterial PGE2	MESH:D059413
7752389	1510	1531	bladder hyperactivity	MESH:D006948
6942642	20	31	hypokalemia	MESH:D007008
6942642	36	55	cardiac arrhythmias	MESH:D001145
6942642	103	153	cornerstone of antihypertensive treatment programs	MESH:D016609
6942642	155	166	Hypokalemia	MESH:D007008
6942642	313	335	diastolic hypertension	OMIM:608622
6942642	1441	1452	hypokalemia	MESH:D007008
6942642	1504	1515	hypokalemia	MESH:D007008
3732088	25	36	arrhythmias	MESH:D001145
3732088	40	69	hypertensive coronary disease	MESH:D003327
3732088	163	182	cardiac arrhythmias	MESH:D001145
3732088	215	238	coronary artery disease	MESH:D003324
3732088	348	404	essential hypertension and known coronary artery disease	MESH:D003324
3732088	1376	1399	ischaemic heart disease	MESH:D006331
2533791	68	79	hepatitis B	MESH:D006509
2533791	176	193	hepatitis B virus	MESH:D006509
2533791	195	198	HBV	MESH:D006509
2533791	333	342	hepatitis	MESH:D006505
2533791	373	382	hepatitis	MESH:D006505
2533791	470	479	hepatitis	MESH:D006505
2533791	553	562	hepatitis	MESH:D006505
2322844	859	871	hyperalgesia	MESH:D006930
2322844	1107	1119	hyperalgesia	MESH:D006930
20552622	19	41	atrial tachyarrhythmia	MESH:D013610
20552622	218	240	atrial tachyarrhythmia	MESH:D013610
20552622	582	592	arrhythmia	MESH:D001145
20552622	637	659	atrial tachyarrhythmia	MESH:D013610
20552622	949	959	arrhythmia	MESH:D001145
20552622	1317	1328	tachycardia	MESH:D013610
20510337	681	686	tumor	MESH:D009369
20164825	51	62	nephropathy	OMIM:161900
20164825	216	236	vascular dysfunction	MESH:D014652
20164825	602	621	acute renal failure	MESH:D058186
20164825	910	928	kidney dysfunction	MESH:D007674
20042557	238	250	hip fracture	MESH:D006620
20042557	517	525	dementia	MESH:D003704
20042557	702	705	BIS
20042557	761	764	BIS
20042557	684	700	bispectral index	OMIM:607447
20042557	904	920	Mental Disorders	MESH:D001523
19944333	18	45	acute myocardial infarction	MESH:D009203
19944333	99	128	advanced renal cell carcinoma	MESH:D002292
19944333	397	422	subendocardial infarction	MESH:D007238
17943461	61	87	AZT-induced cardiomyopathy	MESH:D009202
17943461	101	123	Dilated cardiomyopathy	MESH:D002311
17943461	125	128	DCM
17943461	134	145	myocarditis	MESH:D009205
17943461	211	224	heart failure	MESH:D006333
17943461	348	382	acquired immunodeficiency syndrome	MESH:D000163
17943461	384	388	AIDS	MESH:D000163
17943461	426	457	cardiac and skeletal myopathies	MESH:D006331
17943461	1095	1112	cardiac structure	MESH:D020914
17943461	1174	1190	cardiac dilation	MESH:D006331
17943461	1481	1491	sarcolemma
17943461	1840	1854	cardiomyopathy	MESH:D009202
17943461	1909	1925	cardiac dilation	MESH:D006331
17074608	18	24	chorea	MESH:D002819
17074608	29	43	encephalopathy	MESH:D001925
17074608	47	82	atypical nonketotic hyperglycinemia	MESH:D020158
17074608	84	110	Nonketotic hyperglycinemia	MESH:D020158
17074608	116	149	disorder of amino acid metabolism	MESH:D000592
17074608	356	365	hypotonia	MESH:D009123
17074608	391	414	psychomotor retardation	MESH:D011596
17074608	464	479	hyperglycinemia	MESH:D020158
17074608	583	597	language delay	MESH:D007805
17074608	602	620	mental retardation	MESH:D008607
17074608	644	670	nonketotic hyperglycinemia	MESH:D020158
17074608	703	723	acute encephalopathy	MESH:D020803
16364460	235	247	Morris water	MESH:D008114
15579441	0	7	Hypoxia	MESH:D000860
15579441	11	24	renal disease	MESH:D052177
15579441	30	41	proteinuria	MESH:D011507
15579441	45	72	/or glomerular hypertension	MESH:D007673
15579441	243	254	new hypoxia	MESH:D000860
15579441	290	297	hypoxia	MESH:D000860
15579441	490	539	tubulointerstitial hypoxia in the diseased kidney	MESH:D000860
15579441	591	607	cortical hypoxia	MESH:D000860
15579441	649	667	nephrotic syndrome	MESH:D009404
15579441	682	699	segmental hypoxia	MESH:D000860
15579441	747	754	hypoxia	MESH:D000860
15579441	1079	1086	hypoxia	MESH:D000860
15579441	1134	1159	tubulointerstitial injury	MESH:D009395
15579441	1447	1473	tubulointerstitial hypoxia	MESH:D000860
15579441	1478	1509	progressive glomerular diseases	MESH:D007673
15517007	124	143	autoimmune diseases	MESH:D001327
15517007	171	189	systemic sclerosis	MESH:D012595
15517007	194	212	multiple sclerosis	MESH:D009103
15517007	342	361	autoimmune diseases	MESH:D001327
15517007	758	774	number of deaths	MESH:D003643
15517007	786	802	cardiac toxicity	MESH:D056486
15517007	976	994	systemic sclerosis	MESH:D012595
15517007	1346	1364	autoimmune disease	MESH:D001327
12180796	110	115	tumor	MESH:D009369
12180796	439	444	tumor	MESH:D009369
12109865	1681	1683	UH
12042105	19	34	nephrolithiasis	MESH:D053040
12042105	251	269	metabolic acidosis	MESH:D000138
12042105	512	527	nephrolithiasis	MESH:D053040
12042105	581	596	nephrolithiasis	MESH:D053040
12042105	604	623	urologic literature	MESH:D014570
11868798	80	91	hypokalemia	MESH:D007008
11868798	95	101	cancer	MESH:D009369
11868798	237	281	Selective distal tubular epithelial toxicity	MESH:D056486
11868798	579	590	hypokalemia	MESH:D007008
11868798	594	605	neutropenic	MESH:D044504
11868798	681	704	hematological disorders	MESH:D006402
11868798	849	865	fungal infection	MESH:D008172
11868798	1442	1453	hypokalemia	MESH:D007008
11868798	1492	1503	neutropenic	MESH:D044504
11860278	117	119	DA
11860278	107	115	Dopamine	MESH:D013580
11860278	832	834	WT	MESH:C536751
11860278	1170	1187	neurodegeneration	OMIM:256600
11838826	33	51	hyperprolactinemia	MESH:D006966
11838826	212	230	hyperprolactinemia	MESH:D006966
11838826	310	323	prolactinomas	MESH:D015175
11838826	407	414	puberty	MESH:D011628
11838826	418	431	short stature	OMIM:604271
11838826	535	553	hyperprolactinemia	MESH:D006966
11838826	622	640	hyperprolactinemia	MESH:D006966
11838826	646	657	cabergoline
11838826	760	778	hyperprolactinemia	MESH:D006966
11838826	884	900	Mental Disorders	MESH:D001523
11838826	918	934	bipolar disorder	MESH:D001714
11838826	1558	1576	hyperprolactinemia	MESH:D006966
11467664	93	113	cholestatic jaundice	MESH:D041781
11467664	349	361	portal edema	MESH:D006975
11467664	391	409	acute inflammation	MESH:D007249
11467664	652	687	metformin-associated hepatotoxicity	MESH:D018886
11077455	120	167	vigabatrin-attributed visual field constriction	MESH:D020969
11077455	1577	1590	field defects	MESH:C536633
11063349	232	257	tacrolimus (Tac) toxicity	MESH:D056486
11063349	557	575	facial dysmorphism	OMIM:604168
11063349	581	624	posttransplant lymphoproliferative disorder	MESH:D008232
11063349	626	630	PTLD
11063349	888	906	Facial dysmorphism	OMIM:604168
11063349	947	951	PTLD
11063349	990	999	pneumonia	MESH:D011014
11063349	1005	1017	Pneumocystis	MESH:D016720
11063349	1026	1035	pneumonia	MESH:D011014
11063349	1071	1086	polyclonal PTLD
11063349	1116	1129	bronchiolitis	MESH:D001988
11063349	1233	1237	PTLD
11063349	1563	1575	Pneumocystis	MESH:D016720
11063349	1584	1605	pneumonia prophylaxis	MESH:D011014
10091616	30	41	dyskinesias	MESH:D020820
10091616	55	67	mental tasks	MESH:D008607
10091616	90	109	Parkinson's disease	MESH:D010300
10091616	115	135	disabling dyskinesia	MESH:D020820
10091616	539	555	dyskinesia score	MESH:D020820
9952311	75	89	cardiomyopathy	MESH:D009202
9952311	186	192	cancer	MESH:D009369
9952311	234	268	cumulative cardiovascular toxicity	MESH:D056486
9952311	526	529	ADR
9952311	1090	1093	ADR
9952311	1101	1127	cardiovascular arrhythmias	MESH:D001145
9952311	1226	1229	QRS	MESH:D008151
9952311	1303	1321	heart mitochondria	MESH:D006331
9952311	1440	1458	Such abnormalities	MESH:D002869
9952311	1799	1802	ADR
9915601	0	20	Enhanced bradycardia	MESH:D001919
9915601	153	212	vasodilators and change the accompanying reflex tachycardia	MESH:D013610
9915601	216	227	bradycardia	MESH:D001919
9915601	281	292	brain gamma	MESH:D006362
9915601	382	393	bradycardia	MESH:D001919
9915601	720	734	methylatropine
9758264	652	672	cleft lip and palate	MESH:D002971
9758264	998	1026	systemic lupus erythematodes	MESH:D008180
9758264	1111	1129	autoimmune disease	MESH:D001327
9758264	1386	1404	autoimmune disease	MESH:D001327
9669632	91	115	irritable bowel syndrome	MESH:D043183
9669632	227	263	disordered gastrointestinal motility	MESH:D015835
9669632	361	390	postprandial jejunal motility	MESH:D007579
9669632	411	435	irritable bowel syndrome	MESH:D043183
9669632	437	440	IBS	MESH:D053560
9669632	479	482	IBS	MESH:D053560
9669632	1695	1698	IBS	MESH:D053560
9669632	1834	1837	IBS	MESH:D053560
9669632	2087	2090	IBS	MESH:D053560
9326871	0	46	Clarithromycin-induced ventricular tachycardia	MESH:D017180
9326871	301	316	gastroenteritis	MESH:D005759
9326871	642	666	ventricular dysrhythmias	MESH:D001145
9326871	732	744	dysrhythmias	MESH:D001145
9226773	23	41	diabetes insipidus	MESH:D003919
9226773	122	148	hypernatraemic dehydration	MESH:D003681
9226773	241	271	nephrogenic diabetes insipidus	MESH:D018500
9226773	507	537	nephrogenic diabetes insipidus	MESH:D018500
9226773	555	585	nephrogenic diabetes insipidus	MESH:D018500
9226773	831	861	nephrogenic diabetes insipidus	MESH:D018500
8600333	42	62	malignant bone tumor	MESH:D018198
8600333	120	141	malignant bone tumors	MESH:D018198
8600333	658	674	cardiac toxicity	MESH:D056486
8600333	755	786	complex ventricular arrhythmias	MESH:D001145
8600333	788	813	left ventricular dilation	MESH:D018487
8600333	895	916	cardiac abnormalities	MESH:D006331
8600333	1138	1179	left ventricular posterior wall thickness	MESH:D018487
8514073	408	434	esophagogastroduodenoscopy
8492347	11	25	rhabdomyolysis	MESH:D012206
8492347	121	132	hypokalemia	MESH:D007008
8492347	134	146	hypocalcemia	MESH:D006996
8492347	151	165	hypomagnesemia	MESH:C537153
8492347	180	191	hypokalemia	MESH:D007008
8492347	202	217	muscle weakness	MESH:D018908
8492347	226	240	hypomagnesemia	MESH:C537153
8492347	466	471	obese	MESH:D009765
8492347	486	509	Symptomatic hypokalemia	MESH:D007008
8492347	567	579	hypocalcemia	MESH:D006996
8410199	677	680	GAD
8410199	1032	1035	GAD
8410199	1075	1088	neuronal loss	MESH:D016388
8410199	1118	1121	GAD
8410199	1147	1150	GAD
8410199	1484	1487	GAD
7791169	57	74	renal dysfunction	MESH:C535382
7791169	1508	1525	renal dysfunction	MESH:C535382
3123611	456	481	chorea or rheumatic fever	MESH:D002819
761833	0	24	Reversal of ammonia coma	MESH:D003128
761833	65	77	Ammonia coma	MESH:D003128
761833	359	372	brain ammonia	MESH:C538320
761833	424	450	renal excretion of ammonia	MESH:C538320
761833	577	589	ammonia coma	MESH:D003128
761833	713	757	blood and brain ammonia and the ammonia coma	MESH:C538320
761833	846	858	ammonia coma	MESH:D003128
761833	1072	1087	encephalopathic
18589141	0	32	Heparin-induced thrombocytopenia	MESH:D013921
18589141	219	229	thrombosis	MESH:D013927
18589141	259	291	Heparin-induced thrombocytopenia	MESH:D013921
18589141	293	296	HIT
18589141	730	733	POD
18589141	711	728	postoperative day	MESH:D014786
18589141	1134	1159	hepatic artery thrombosis	MESH:D002341
18589141	1682	1697	UFH-related HIT	MESH:D019973
16418614	0	25	PTU-associated vasculitis	MESH:D014657
16418614	41	56	Turner Syndrome	MESH:D014424
16418614	61	76	Graves' disease	MESH:D006111
16418614	250	260	vasculitis	MESH:D014657
16418614	393	408	Turner syndrome	MESH:D014424
16418614	413	428	Graves' disease	MESH:D006111
16418614	749	775	persistent hyperthyroidism	MESH:D006980
16418614	836	846	vasculitis	MESH:D014657
15893386	218	240	malignant hyperthermia	MESH:D008305
15893386	716	738	malignant hyperthermia	MESH:D008305
15814210	6	30	neurological dysfunction	MESH:D009461
15814210	218	242	neurological dysfunction	MESH:D009461
15814210	649	657	asphyxia	MESH:D001237
15814210	779	807	periventricular leukomalacia	MESH:D007969
15814210	820	843	psychomotor retardation	MESH:D011596
15814210	902	927	neurological dysfunctions	MESH:D009461
15814210	1524	1549	neurological dysfunctions	MESH:D009461
11912119	36	47	dyskinesias	MESH:D020820
11912119	219	247	levodopa-induced dyskinesias	MESH:D004409
11912119	249	252	LID
11912119	362	390	levodopa-induced dyskinesias	MESH:D004409
11912119	601	613	OFF levodopa
11912119	695	698	LID
11912119	1167	1170	LID
11912119	1291	1312	peak-dose dyskinesias	MESH:D020820
11912119	1573	1576	LID
11912119	1670	1681	dyskinesias	MESH:D020820
9105126	15	40	ventricular septal defect	MESH:D006345
8599504	0	10	Angioedema	MESH:D000799
8599504	54	64	Angioedema	MESH:D000799
8599504	80	99	angioneurotic edema	MESH:D000799
8599504	103	120	Quincke's disease	MESH:D000799
8599504	332	342	angioedema	MESH:D000799
8599504	348	366	significant tongue	MESH:D014060
8546130	66	87	chronic renal failure	MESH:D007676
8546130	184	197	renal failure	MESH:D051437
8546130	217	223	uremia	MESH:D014511
8546130	404	427	end-stage renal disease	MESH:D007676
8546130	492	496	CAPD
8546130	429	433	ESRD	MESH:D007676
8546130	449	490	continuous ambulatory peritoneal dialysis	MESH:D010538
8546130	578	591	renal failure	MESH:D051437
8546130	610	618	anephric
8546130	820	833	renal failure	MESH:D051437
8546130	939	943	ESRD	MESH:D007676
7724492	0	20	Acute renal toxicity	MESH:D056486
7724492	130	144	renal toxicity	MESH:D056486
7724492	205	223	glomerulonephritis	MESH:D005921
7724492	487	489	DX
7724492	519	530	proteinuria	MESH:D011507
7724492	662	680	glomerulonephritis	MESH:D005921
7724492	1230	1239	nephrosis	MESH:D009401
7619765	0	39	Etoposide-related myocardial infarction	MESH:D009203
7619765	61	82	myocardial infarction	MESH:D009203
7619765	170	192	coronary heart disease	MESH:D003327
7416947	667	690	rheumatic heart disease	MESH:D012214
7263204	6	21	aplastic anemia	MESH:D000741
7263204	150	165	aplastic anemia	MESH:D000741
7263204	273	288	aplastic anemia	MESH:D000741
7263204	578	593	aplastic anemia	MESH:D000741
7066357	69	87	nephrotic syndrome	MESH:D009404
7066357	232	250	nephrotic syndrome	MESH:D009404
7066357	300	318	nephrotic syndrome	MESH:D009404
7066357	583	601	nephrotic syndrome	MESH:D009404
7066357	617	628	albuminuria	MESH:D000419
7066357	1528	1543	lipoproteinuria
7066357	1856	1870	nephrotic rats	MESH:D009404
7007443	34	56	acute hepatic necrosis	MESH:D015882
7007443	516	531	viral hepatitis	MESH:D006525
3762968	59	73	encephalopathy	MESH:D001925
3762968	152	160	diabetic	MESH:D003929
3762968	194	208	encephalopathy	MESH:D001925
3762968	382	423	postalcoholic Wernicke-Korsakoff syndrome	MESH:D020915
3762968	545	559	encephalopathy	MESH:D001925
3762968	696	710	encephalopathy	MESH:D001925
3762968	825	852	Wernicke-Korsakoff syndrome	MESH:D020915
3762968	904	918	encephalopathy	MESH:D001925
3413271	14	33	myocardial ischemia	MESH:D017202
3413271	91	99	ischemia	MESH:D007511
3413271	138	157	myocardial ischemia	MESH:D017202
3413271	188	211	coronary artery disease	MESH:D003324
3413271	232	240	ischemia	MESH:D007511
3413271	404	423	myocardial ischemia	MESH:D017202
3413271	466	472	angina	MESH:D017566
3413271	501	520	myocardial ischemia	MESH:D017202
3413271	614	633	myocardial ischemia	MESH:D017202
3413271	786	794	ischemia	MESH:D007511
3413271	952	960	ischemia	MESH:D007511
3088349	196	205	SN lesion	MESH:D001768
3088349	724	735	DA turnover
3001299	175	205	nephrogenic diabetes insipidus	MESH:D018500
3001299	210	224	hypothyroidism	MESH:D007037
3001299	388	402	Hypothyroidism	MESH:D007037
3001299	509	520	hypothyroid	MESH:D007037
3001299	541	552	hypothyroid	MESH:D007037
2004015	115	122	anaemia
2004015	221	225	AIDS	MESH:D000163
2004015	265	288	LP-BM5 murine leukaemia	MESH:D016183
2004015	331	338	anaemia
2004015	473	492	LP-BM5 MuLV disease	MESH:D004194
2004015	567	574	anaemia
2004015	632	639	anaemia
2004015	1210	1217	anaemia
2004015	1379	1382	AZT
2004015	1428	1435	anaemia
2004015	1446	1461	reticulocytosis	MESH:D045262
2004015	1498	1505	anaemia
2004015	1568	1575	anaemia
1732442	30	56	adrenergic neuron activity	OMIM:612348
1732442	79	93	cardiomyopathy	MESH:D009202
1732442	99	133	iodine-125-metaiodobenzylguanidine	OMIM:274400
1732442	236	263	adrenergic neuron integrity	MESH:D009410
1732442	318	332	cardiomyopathy	MESH:D009202
1732442	364	407	abnormal cardiac adrenergic neuron activity	OMIM:612348
1732442	458	483	adriamycin cardiomyopathy	MESH:D009202
1732442	499	520	vacuolar degeneration	MESH:C536522
1732442	524	534	myocardial	MESH:D009202
1732442	666	687	isolated degeneration	MESH:C536289
1732442	892	914	extensive degeneration	MESH:D054908
1732442	1720	1746	adrenergic neuron activity	OMIM:612348
1732442	1773	1794	myocardial impairment	MESH:D009202
1732442	1815	1836	vacuolar degeneration	MESH:C536522
1732442	1930	1944	cardiomyopathy	MESH:D009202
1423339	0	17	Amnestic syndrome	MESH:D000425
1423339	101	133	Alzheimer-like subacute dementia	MESH:D000544
921394	591	602	tachycardia	MESH:D013610
1355091	637	640	MAP	MESH:C535477
1355091	1109	1112	MAP	MESH:C535477
8638876	41	75	internal carotid artery thrombosis	MESH:D002341
8638876	152	211	premenopausal woman developed headache, nausea and vomiting	MESH:D020250
8638876	303	320	Diabetes mellitus	MESH:D003920
8638876	322	324	DM	MESH:C538008
8638876	354	373	Computed tomography
8638876	383	402	hemorrhagic infarct	MESH:D007238
8638876	483	486	SSS	OMIM:163800
8638876	467	481	sagittal sinus	MESH:D020225
8638876	617	620	SSS	OMIM:163800
8638876	625	687	inferior sagittal sinus, suggestive of venous sinus thrombosis	MESH:D020225
8638876	886	923	DM increased vascular thrombogenicity	MESH:C538008
8638876	965	975	thrombosis	MESH:D013927
1628552	0	40	Chloroquine related complete heart block	MESH:C535758
1628552	46	55	blindness	MESH:D001766
1628552	171	194	deterioration of vision	MESH:D014786
1628552	216	224	dyspnoea
1628552	251	267	syncopal attacks	MESH:D013575
1628552	318	341	chloroquine retinopathy	MESH:D003930
1628552	383	396	heart failure	MESH:D006333
1628552	403	423	complete heart block	MESH:C535758
1628552	495	536	pacemaker insertion and the heart failure	MESH:D006333
11524350	0	17	Systemic toxicity	MESH:D056486
11524350	1000	1012	dysrhythmias	MESH:D001145
10027919	38	57	hyperparathyroidism	MESH:D006961
10027919	84	92	turnover
10027919	106	119	renal failure	MESH:D051437
10027919	222	235	renal failure	MESH:D051437
10027919	273	286	hypercalcemia	MESH:D006934
10027919	316	329	bone turnover	MESH:D001847
10027919	349	370	adynamic bone disease	MESH:D001847
10027919	1390	1409	renal insufficiency	MESH:D051437
10027919	1438	1457	hyperparathyroidism	MESH:D006961
10027919	1703	1716	hypercalcemia	MESH:D006934
10027919	1721	1738	hyperphosphatemia	MESH:D054559
10027919	1976	1996	osteoid and fibrosis	MESH:D010017
10027919	2048	2056	turnover
10027919	2287	2300	hypercalcemia	MESH:D006934
10027919	2327	2346	renal insufficiency	MESH:D051437
10027919	2396	2415	hyperparathyroidism	MESH:D006961
10027919	2452	2460	turnover
10027919	2507	2528	adynamic bone disease	MESH:D001847
8643966	36	62	non-small cell lung cancer	MESH:D002289
8643966	191	205	antineoplastic
8643966	266	282	breast carcinoma	MESH:D058922
8643966	386	415	IV non-small cell lung cancer	MESH:D002289
8643966	543	553	leukopenia	MESH:D007970
8643966	1116	1138	Hematologic toxicities	MESH:D056486
8643966	1249	1263	polyneuropathy	MESH:D011115
8643966	1328	1342	polyneuropathy	MESH:D011115
8643966	1368	1375	myalgia	MESH:D011000
8643966	1376	1386	arthralgia	MESH:D018771
8643966	1474	1482	vomiting	MESH:D014839
8643966	1772	1811	hematologic and nonhematologic toxicity	MESH:D056486
6637851	68	91	ventricular tachycardia	MESH:D017180
6637851	95	119	ventricular fibrillation	MESH:D014693
6637851	196	219	ventricular tachycardia	MESH:D017180
6637851	221	223	VT
6637851	515	545	VT or ventricular fibrillation	MESH:D014693
6637851	1107	1119	visual halos	MESH:D012640
6637851	1138	1168	thyroid function abnormalities	MESH:D011681
6637851	1545	1547	VT
8800187	653	656	QRS	MESH:D008151
8800187	675	686	bradycardia	MESH:D001919
8800187	934	937	QRS	MESH:D008151
8800187	1029	1052	ventricular arrhythmias	MESH:D001145
8800187	1310	1360	cardiovascular and central nervous system toxicity	MESH:D020265
7707116	55	68	neuroblastoma	MESH:D009447
7707116	130	143	neuroblastoma	MESH:D009447
7707116	291	304	neuroblastoma	MESH:D009447
7707116	457	460	MTD
7707116	564	577	neuroblastoma	MESH:D009447
7707116	431	455	maximal-tolerated dosage	MESH:C535601
7707116	1111	1124	hypercalcemia	MESH:D006934
7707116	1152	1158	anemia	MESH:D000740
7707116	1159	1175	thrombocytopenia	MESH:D013921
7707116	1396	1399	MTD
7707116	1625	1638	neuroblastoma	MESH:D009447
7707116	1680	1683	DLT
7707116	1693	1706	hypercalcemia	MESH:D006934
6892185	803	832	autonomic and motor phenomena	MESH:D001342
6892185	841	850	mydriasis	MESH:D015878
6892185	852	887	tremor and clonic-tonic convulsions	MESH:D004830
6216862	67	87	rheumatoid arthritis	MESH:D001172
6216862	115	143	systemic lupus erythematosus	MESH:D008180
6216862	145	157	polymyositis	MESH:D017285
6216862	162	179	myasthenia gravis	MESH:D009157
6216862	262	282	rheumatoid arthritis	MESH:D001172
6216862	340	351	skin lesion	MESH:D012871
6216862	458	474	Wilson's disease	MESH:D006527
6216862	500	520	rheumatoid arthritis	MESH:D001172
2004	33	52	cardiac arrhythmias	MESH:D001145
2004	379	402	ventricular tachycardia	MESH:D017180
2004	451	479	Supraventricular tachycardia	MESH:D013617
2004	684	704	U wave abnormalities	MESH:C536925
2004	740	763	ventricular arrhythmias	MESH:D001145
2004	996	1012	tachyarrhythmias	MESH:D013610
2004	1176	1200	antecedent heart disease	MESH:D006331
2004	1208	1227	cardiac arrhythmias	MESH:D001145
2004	1271	1284	heart disease	MESH:D006331
3703509	0	27	Hyperglycemic acidotic coma	MESH:D006944
3703509	41	62	Kearns-Sayre syndrome	MESH:D007625
3703509	290	300	polyphagia
3703509	306	314	polyuria	MESH:D011141
3703509	367	384	coma, hypotension	MESH:D003128
3703509	393	406	hyperglycemia	MESH:D006943
3703509	412	420	acidosis	MESH:D000138
3703509	472	479	ketosis	MESH:D007662
3703509	542	569	Respiratory failure rapidly	MESH:D012131
3703509	748	769	Kearns-Sayre syndrome	MESH:D007625
20683499	1411	1430	attenuated learning	MESH:D007859
20683499	1618	1636	cognitive deficits	MESH:D003072
20683499	1701	1727	neurodegenerative diseases	MESH:D019636
20466178	0	22	Rosaceiform dermatitis	MESH:D003872
20466178	197	214	facial dermatitis	MESH:D003872
20466178	238	259	showed telangiectasia	MESH:D005254
20466178	473	495	rosaceiform dermatitis	MESH:D003872
19944736	336	339	BBB	OMIM:145410
19944736	315	334	blood-brain barrier	MESH:C536830
19944736	886	897	Wistar rats	MESH:D011906
19721134	249	255	guinea	MESH:D004320
19721134	469	480	arrhythmias	MESH:D001145
19721134	511	534	ventricular tachycardia	MESH:D017180
19721134	561	571	arrhythmia	MESH:D001145
17786501	50	60	neuropathy	MESH:D003929
17786501	123	133	neuropathy	MESH:D003929
17786501	400	408	numbness	MESH:D006987
16960342	63	74	hepatitis B	MESH:D006509
16960342	144	161	Hepatitis B virus	MESH:D006509
16960342	163	166	HBV	MESH:D006509
16960342	192	207	liver cirrhosis	MESH:D008103
16960342	212	236	hepatocellular carcinoma	MESH:D006528
16960342	1174	1183	hepatitis	MESH:D006505
16960342	1317	1320	HBV	MESH:D006509
16960342	1329	1338	cirrhosis	MESH:D005355
11226639	49	57	narcosis	MESH:D053608
11226639	175	183	narcosis	MESH:D053608
11226639	830	838	narcosis	MESH:D053608
11226639	878	902	pharmacological narcosis	MESH:D053608
8766220	206	212	cancer	MESH:D009369
8441146	17	37	rheumatoid arthritis	MESH:D001172
8441146	148	176	erosive rheumatoid arthritis	MESH:D001172
8441146	178	180	RA	MESH:D001172
8441146	263	278	aplastic anemia	MESH:D000741
3653576	383	397	nephrotoxicity
3653576	979	1002	Proximal tubular damage	MESH:D005198
3653576	1013	1017	HCBD
1899352	495	516	microscopic hematuria	MESH:D006417
1899352	574	595	macroscopic hematuria	MESH:D006417
1899352	693	711	Grade 2 leukopenia	MESH:D007970
1899352	1046	1055	hematuria	MESH:D006417
1899352	1192	1201	hematuria	MESH:D006417
1899352	1467	1500	trial of standard bolus schedules	MESH:D020178
18161408	244	259	Thromboembolism	MESH:D013923
18161408	358	360	CC
18161408	374	393	coronary thrombosis	MESH:D003328
18161408	397	412	thromboembolism	MESH:D013923
18161408	495	516	myocardial infarction	MESH:D009203
18161408	518	520	MI
18161408	759	794	anterior wall myocardial infarction	MESH:D056988
18161408	1192	1194	CC
18161408	1199	1220	myocardial infarction	MESH:D009203
18161408	1222	1232	Thrombosis	MESH:D013927
17574447	0	14	Hepatonecrosis
17574447	19	30	cholangitis	MESH:D002761
17574447	303	324	chronic liver disease	MESH:D008107
17574447	408	410	PB
17574447	487	503	bronchopneumonia	MESH:D001996
17574447	1071	1129	PB-related asymptomatic chronic hepatic enzyme dysfunction	MESH:D058070
16710500	28	38	neuropathy	MESH:D003929
16710500	93	105	tuberculosis	MESH:D014376
16710500	188	199	visual loss	MESH:D012640
16710500	240	261	bitemporal hemianopia	MESH:D006423
16710500	335	345	neuropathy	MESH:D003929
16710500	380	409	loss of central visual acuity	MESH:D012640
16710500	482	500	bitemporal flavour	MESH:D006423
16710500	922	933	visual loss	MESH:D012640
16710500	1089	1101	chiasmopathy
11694026	74	83	urticaria	MESH:D014581
11694026	84	94	angioedema	MESH:D000799
11694026	476	485	urticaria	MESH:D014581
11694026	486	496	angioedema	MESH:D000799
11694026	772	781	urticaria	MESH:D014581
11694026	782	792	angioedema	MESH:D000799
11694026	1185	1194	urticaria	MESH:D014581
11694026	1195	1205	angioedema	MESH:D000799
11694026	1209	1219	angioedema	MESH:D000799
11694026	1243	1260	chronic urticaria	MESH:D014581
11694026	1426	1435	urticaria	MESH:D014581
11694026	1436	1446	angioedema	MESH:D000799
11694026	1571	1588	chronic urticaria	MESH:D014581
11694026	1635	1645	angioedema	MESH:D000799
11282081	24	43	atrial fibrillation	MESH:D001281
11282081	107	125	Atrial tachycardia	MESH:D013612
11282081	188	207	atrial fibrillation	MESH:D001281
11282081	209	211	AF
11282081	461	463	AF
11282081	638	646	atropine
11282081	1452	1469	atrial conduction	MESH:D019955
11282081	1847	1864	atrial conduction	MESH:D019955
11282081	2190	2204	autonomic tone	MESH:D001342
10074612	13	24	bradycardia	MESH:D001919
10074612	143	154	bradycardia	MESH:D001919
10074612	358	382	ischemic cardiac disease	MESH:D006331
10074612	432	456	pulmonary-renal syndrome	MESH:C538458
10074612	462	472	hemoptysis	MESH:D006469
10074612	494	507	renal failure	MESH:D051437
10074612	513	522	hypoxemia	MESH:D000860
10074612	725	747	ventricular arrhythmia	MESH:D001145
10074612	803	815	sudden death	MESH:D003645
10074612	1031	1046	cardiac disease	MESH:D006331
10074612	1110	1149	authors discount ventricular arrhythmia	MESH:D001145
9209318	62	76	myelodysplasia	MESH:D009436
9209318	96	113	macrocytic anemia	MESH:D000748
9209318	117	121	AIDS	MESH:D000163
9209318	791	807	thrombocytopenia	MESH:D013921
9209318	839	863	myelodysplastic syndrome	MESH:D009190
9209318	865	868	MDS	MESH:D054221
9209318	944	971	hypocellular myelodysplasia	MESH:D009436
9209318	986	1031	hypersegmented myelodysplastic granulocytosis	MESH:D009190
9209318	1129	1152	megakaryocytic myelosis	MESH:D007947
9209318	1171	1183	hyperplastic	MESH:D000796
9209318	1192	1207	dysmyelopoiesis
9209318	1251	1265	myelodysplasia	MESH:D009436
9209318	1271	1288	dyserythropoiesis
9209318	1290	1303	hemosiderosis	MESH:D006486
9209318	1498	1522	myelodysplastic syndrome	MESH:D009190
8742498	525	528	AAP
8742498	1038	1041	NAD	MESH:D016111
8742498	1148	1151	AAP
8742498	1304	1313	hepatitis	MESH:D006505
8742498	1418	1427	hepatitis	MESH:D006505
2435991	62	85	ventricular arrhythmias	MESH:D001145
2435991	165	188	ventricular arrhythmias	MESH:D001145
2435991	298	308	arrhythmia	MESH:D001145
2435991	362	373	arrhythmias	MESH:D001145
2435991	427	438	arrhythmias	MESH:D001145
2435991	731	760	adrenaline-induced arrhythmia	MESH:D001145
2435991	820	831	arrhythmias	MESH:D001145
950631	41	59	glomerular disease	MESH:D007673
950631	80	100	rheumatoid arthritis	MESH:D001172
950631	111	128	heavy proteinuria	MESH:D011507
950631	477	505	mesangial cell hyperactivity	MESH:C537346
950631	642	671	membranous glomerulonephritis	MESH:D015433
19319147	403	427	hemorrhagic blood volume	MESH:D006402
19319147	848	851	PCC	OMIM:601286
19319147	942	966	hemorrhagic blood volume	MESH:D006402
19319147	1216	1231	large hematomas	MESH:D006406
19319147	1270	1287	extensive lesions	MESH:D001768
19319147	1363	1366	PCC	OMIM:601286
19319147	1433	1457	hemorrhagic blood volume	MESH:D006402
16471092	817	825	nocturia	MESH:D053158
16471092	1211	1243	social function and mental heath	OMIM:300082
16471092	1352	1355	OAB
16174948	11	91	acute cerebral vasoconstriction after cocaine-associated subarachnoid hemorrhage	MESH:D013345
16174948	144	171	neurovascular complications	MESH:D013901
16174948	183	223	arterial vasoconstriction and vasculitis	MESH:D014657
16174948	399	441	cocaine-associated subarachnoid hemorrhage	MESH:D013345
16174948	1861	1891	distal narrowing or vasculitis	MESH:D014657
15042318	79	95	gastric lymphoma	MESH:C535648
15042318	114	132	myotonic dystrophy	MESH:D009223
15042318	223	239	gastric lymphoma	MESH:C535648
15042318	244	262	myotonic dystrophy	MESH:D009223
15042318	294	312	muscular dystrophy	MESH:D009136
15042318	318	344	sudden atrial fibrillation	MESH:D001281
15042318	420	439	Atrial fibrillation	MESH:D001281
15042318	457	468	arrhythmias	MESH:D001145
15042318	538	554	cardiac toxicity	MESH:D056486
15042318	668	678	arrhythmia	MESH:D001145
12448656	44	75	metastatic renal cell carcinoma	MESH:C538445
12448656	168	196	metastatic renal cell cancer	MESH:D002292
12448656	1193	1213	renal cell carcinoma	MESH:D002292
12448656	1403	1423	renal cell carcinoma	MESH:D002292
12231232	367	400	parkinsonian-like muscle rigidity	MESH:D009127
11847945	6	27	cholestatic hepatitis	MESH:D041781
11847945	95	116	cholestatic hepatitis	MESH:D041781
11847945	247	270	cholestatic hepatitis 3	MESH:D041781
11847945	414	423	hepatitis	MESH:D006505
11847945	805	824	halothane hepatitis	MESH:D006505
11847945	935	956	cholestatic hepatitis	MESH:D041781
11284996	93	122	chronic tension-type headache	MESH:D018781
11284996	433	486	chronic tension-type headache and 16 healthy controls	MESH:D018781
11078231	0	19	Myocardial ischemia	MESH:D017202
11078231	128	131	DSE
11078231	175	194	myocardial ischemia	MESH:D017202
11078231	92	126	Dobutamine stress echocardiography	MESH:D054549
11078231	426	445	myocardial ischemia	MESH:D017202
11078231	628	643	anginal attacks	MESH:D016584
11078231	798	822	coronary artery stenosis	MESH:D023921
11078231	1355	1378	coronary artery disease	MESH:D003324
11078231	1395	1412	coronary stenosis	MESH:D023921
10523326	425	427	NO	MESH:D002311
10523326	819	822	MDA
10523326	855	858	NOS
10523326	802	817	malondialdehyde
10523326	1083	1100	renal tissue eNOS	MESH:D059226
10523326	1660	1683	renal and vascular eNOS	MESH:D014652
9867728	9	31	valvular heart disease	MESH:D006349
9867728	257	293	dexfenfluramine had valvular disease	MESH:D006349
9867728	393	415	valvular abnormalities	MESH:D006349
9867728	818	830	valvulopathy
9867728	1164	1186	valvular heart disease	MESH:D006349
9867728	1342	1362	aortic insufficiency	MESH:D001022
9867728	1418	1440	valvular heart disease	MESH:D006349
9636837	568	579	Wistar rats	MESH:D011906
9636837	976	995	dorsal root ganglia	MESH:D011843
9636837	1240	1259	dorsal root ganglia	MESH:D011843
9579567	20	41	endometrial carcinoma	MESH:D016889
9579567	62	75	breast cancer	MESH:D001943
9579567	158	174	Contre le Cancer	MESH:D009369
9579567	219	232	breast cancer	MESH:D001943
9579567	287	300	breast cancer	MESH:D001943
9579567	410	428	endometrial cancer	MESH:D016889
9579567	488	501	breast cancer	MESH:D001943
9579567	536	554	endometrial cancer	MESH:D016889
9579567	571	584	breast cancer	MESH:D001943
9579567	650	663	breast cancer	MESH:D001943
9579567	804	822	endometrial cancer	MESH:D016889
9579567	1395	1413	endometrial cancer	MESH:D016889
9579567	1450	1466	advanced disease	MESH:D020178
9579567	1504	1522	endometrial cancer	MESH:D016889
9579567	1610	1628	endometrial cancer	MESH:D016889
9579567	1679	1692	breast cancer	MESH:D001943
9579567	1705	1724	Pelvic radiotherapy	MESH:D034161
9579567	1779	1792	breast cancer	MESH:D001943
9579567	1794	1813	Endometrial cancers	MESH:D016889
9579567	1911	1924	breast cancer	MESH:D001943
9579567	2091	2104	breast cancer	MESH:D001943
9205462	248	266	gynecologic tumors	MESH:D005831
9205462	376	392	breast carcinoma	MESH:D058922
9205462	623	628	tumor	MESH:D009369
9205462	687	704	liver dysfunction	MESH:D008107
9205462	749	755	tumors	MESH:D009369
9098464	18	29	adenomyosis	MESH:D004715
9098464	46	64	hyperprolactinemia	MESH:D006966
9098464	147	158	adenomyosis	MESH:D004715
9098464	172	185	Wistar albino
9098464	311	329	hyperprolactinemia	MESH:D006966
9098464	362	373	adenomyosis	MESH:D004715
9098464	482	500	hyperprolactinemia	MESH:D006966
9098464	1198	1209	adenomyosis	MESH:D004715
9098464	1351	1361	myometrial
9098464	1422	1441	myometrial invasion	MESH:D009361
9098464	1445	1463	endometrial stroma	MESH:D014591
9098464	1504	1515	adenomyosis	MESH:D004715
7880714	1029	1049	auditory dysfunction	MESH:D001304
6769133	211	235	congestive heart failure	MESH:D006333
6769133	377	395	myocardial lesions	MESH:D009202
6769133	427	463	anthracycline-induced cardiomyopathy	MESH:D009202
6769133	495	522	acute myeloblastic leukemia	MESH:D015470
6769133	735	743	leukemia	MESH:D007938
6292680	0	26	Doxorubicin cardiomyopathy	MESH:D009202
6292680	55	66	Wilms tumor	MESH:D009396
6292680	86	116	Wilms tumor of the left kidney	MESH:D009396
6292680	136	164	anthracycline cardiomyopathy	MESH:D009202
6292680	190	195	tumor	MESH:D009369
6292680	244	258	cardiomyopathy	MESH:D009202
6292680	319	330	Wilms tumor	MESH:D009396
6292680	527	557	Wilms tumor of the left kidney	MESH:D009396
3969369	199	223	prostate adenocarcinomas	MESH:D000230
3969369	379	394	prostate cancer	MESH:D011471
3969369	453	465	gross tumors	MESH:C536704
3969369	492	510	microscopic tumors	MESH:D046728
3969369	666	681	prostate cancer	MESH:D011471
3969369	738	740	SD	MESH:D029461
3969369	766	781	prostate cancer	MESH:D011471
3969369	722	736	Sprague-Dawley
3969369	810	812	SD	MESH:D029461
3969369	878	889	prostatitis	MESH:D053448
3969369	990	1018	experimental prostate cancer	MESH:D011471
3108839	33	48	uremic syndrome	MESH:D006463
3108839	73	98	Hemolytic Uremic Syndrome	MESH:D006463
3108839	100	103	HUS	MESH:C531700
3108839	201	234	microangiopathic hemolytic anemia	MESH:D011697
3108839	236	252	thrombocytopenia	MESH:D013921
3108839	269	282	renal failure	MESH:D051437
3108839	384	397	renal failure	MESH:D051437
3108839	511	524	renal failure	MESH:D051437
3108839	528	543	pulmonary edema	MESH:D011654
3108839	545	558	Renal lesions	MESH:D001768
3108839	599	602	HUS	MESH:C531700
3108839	942	964	gastric adenocarcinoma	MESH:D000230
3108839	979	992	renal failure	MESH:D051437
3108839	997	1013	thrombocytopenia	MESH:D013921
2466960	133	149	cardiac toxicity	MESH:D056486
2466960	378	390	solid tumors	MESH:D059327
2466960	427	435	ischemic	MESH:D002545
2466960	554	570	Anginal episodes	OMIM:160120
2466960	855	863	ischemic	MESH:D002545
2466960	1206	1229	coronary artery disease	MESH:D003324
2466960	1255	1267	sudden death	MESH:D003645
2466960	1449	1457	ischemia	MESH:D007511
2466960	1492	1515	coronary artery disease	MESH:D003324
2320800	66	79	breast cancer	MESH:D001943
2320800	96	119	impaired renal function	OMIM:608852
2320800	149	171	advanced breast cancer	MESH:D001943
2320800	241	254	renal failure	MESH:D051437
2320800	260	266	anuria	MESH:D001002
2320800	307	324	Postrenal failure	MESH:D051437
2320800	400	413	renal failure	MESH:D051437
2320800	502	508	anuria	MESH:D001002
2320800	649	662	tubulopathies	MESH:C557674
2220369	0	23	Central vein thrombosis	MESH:D012170
2220369	236	253	advanced glaucoma	MESH:D005901
2220369	327	347	adrenergic eye drops	MESH:D013575
326460	39	50	hypokalemia	MESH:D007008
326460	129	140	hypokalemia	MESH:D007008
20331935	228	246	hyperprolactinemia	MESH:D006966
20331935	250	281	trabecular bone mineral density	MESH:D000236
20331935	283	286	BMD	MESH:C537666
20331935	559	586	Anthropometric measurements
20331935	766	769	BMD	MESH:C537666
20331935	864	893	areal BMD of the lumbar spine	MESH:C537666
20331935	957	975	Hyperprolactinemia	MESH:D006966
20331935	1153	1171	hyperprolactinemia	MESH:D006966
20331935	1211	1214	BMD	MESH:C537666
20331935	1386	1400	volumetric BMD	MESH:C537666
20331935	1591	1594	BMD	MESH:C537666
20331935	1623	1626	BMD	MESH:C537666
20331935	1881	1899	hyperprolactinemia	MESH:D006966
20331935	1966	1984	hyperprolactinemia	MESH:D006966
20331935	2013	2016	BMD	MESH:C537666
19692487	54	62	polyuria	MESH:D011141
19692487	141	149	polyuria	MESH:D011141
19692487	312	320	polyuria	MESH:D011141
19692487	324	338	mice deficient	MESH:D003677
19692487	498	508	hyposmotic
19692487	693	701	polyuria	MESH:D011141
19692487	1544	1552	polyuria	MESH:D011141
18627295	0	47	Doxorubicin cardiomyopathy-induced inflammation	MESH:D007249
18627295	351	369	DOX cardiomyopathy	MESH:D009202
18627295	428	448	cardiac inflammation	MESH:D007249
18627295	494	508	cardiomyopathy	MESH:D009202
18627295	534	553	cardiac dysfunction	MESH:D006331
18627295	725	742	cardiac apoptosis	MESH:D006331
18627295	875	894	cardiac dysfunction	MESH:D006331
18627295	1103	1121	DOX cardiomyopathy	MESH:D009202
18627295	1297	1315	DOX cardiomyopathy	MESH:D009202
18405372	31	44	sulfasalazine
18405372	48	70	inflammatory arthritis	MESH:D001168
18405372	1249	1261	eosinophilia	MESH:D004802
18405372	1283	1292	nephritis	MESH:D009393
18356633	180	199	febrile neutropenia	MESH:D009503
18356633	690	720	hematologic/oncologic disorder	MESH:D006402
18356633	856	870	nephrotoxicity
18356633	1035	1049	nephrotoxicity
18356633	1301	1315	nephrotoxicity
15638391	83	101	hyperprolactinemia	MESH:D006966
15638391	179	197	hyperprolactinemia	MESH:D006966
15638391	223	226	HAL	MESH:C538320
15638391	210	221	haloperidol
15638391	835	846	hypertrophy	MESH:D006984
15638391	851	896	epithelium hyperplasia of the glandular ducts	MESH:D009375
15531665	343	358	atherosclerosis	MESH:D050197
15531665	457	479	cardiovascular disease	MESH:D002318
15531665	557	585	total cardiovascular disease	MESH:D002318
15531665	597	620	coronary artery disease	MESH:D003324
15531665	820	843	coronary artery disease	MESH:D003324
15531665	912	934	cardiovascular disease	MESH:D002318
15531665	1089	1117	total cardiovascular disease	MESH:D002318
15531665	1283	1306	coronary artery disease	MESH:D003324
15531665	1637	1659	cardiovascular disease	MESH:D002318
15531665	1794	1816	cardiovascular disease	MESH:D002318
12851669	176	191	thromboembolism	MESH:D013923
12842176	108	121	neurotoxicity	MESH:D020258
12842176	1949	1973	neurobehavioral toxicity	MESH:D056486
12571256	129	140	nephropathy	OMIM:161900
12571256	2227	2238	Nephropathy	OMIM:161900
9514561	485	509	seven healthy volunteers
9165568	12	30	malignant syndrome	MESH:D016609
9165568	36	47	risperidone
9165568	61	79	malignant syndrome	MESH:D016609
9165568	162	175	basal ganglia	MESH:D001480
9165568	513	543	neuroleptic malignant syndrome	MESH:D009459
9165568	597	627	neuroleptic malignant syndrome	MESH:D009459
9165568	898	928	neuroleptic malignant syndrome	MESH:D009459
9154656	70	94	acute nephrotic syndrome	MESH:D009404
9154656	203	221	nephrotic syndrome	MESH:D009404
9154656	223	225	NS	MESH:D056770
8911359	28	42	bladder cancer	MESH:D001749
8911359	197	214	urothelial cancer	MESH:D009369
8911359	333	347	bladder cancer	MESH:D001749
8911359	376	382	tumors	MESH:D009369
8911359	419	428	carcinoma	MESH:D002277
8911359	641	657	extensive cancer	MESH:D009369
8911359	668	701	partial cystectomy for palliation	MESH:D004828
8911359	768	781	bladder tumor	MESH:D001749
8911359	788	806	aggressive disease	MESH:D006929
8911359	889	903	bladder tumors	MESH:D001749
8607407	69	90	systemic hypertension	MESH:D006973
8111719	38	51	neurotoxicity	MESH:D020258
8111719	256	269	mental status	MESH:D013226
8111719	777	790	neurotoxicity	MESH:D020258
7059267	29	39	neuropathy	MESH:D003929
7059267	133	155	toxic optic neuropathy	MESH:D056486
7059267	218	229	Visual loss	MESH:D012640
7059267	386	396	neuropathy	MESH:D003929
7059267	451	462	visual loss	MESH:D012640
6381653	0	27	Levodopa-induced dyskinesia	MESH:D004409
6381653	32	43	thalamotomy
6381653	45	72	Levodopa-induced dyskinesia	MESH:D004409
6381653	268	330	ventralis oralis anterior and posterior nuclei of the thalamus	MESH:D001039
6381653	412	423	dyskinesias	MESH:D020820
3950060	24	38	nephrotoxicity
3950060	178	192	nephrotoxicity
3950060	976	990	nephrotoxicity
3950060	1209	1220	nephrotoxic
3311455	775	797	chronic nephrotoxicity	MESH:D002908
3311455	1016	1038	chronic nephrotoxicity	MESH:D002908
2051906	120	140	primary polymyositis	MESH:D017285
2051906	174	187	liver disease	MESH:D008107
2021202	139	158	glomerular function	MESH:D007673
1848636	637	648	hypokalemia	MESH:D007008
1445986	0	41	Cefotetan-induced immune hemolytic anemia	MESH:D000743
1445986	50	66	hemolytic anemia	MESH:D000743
1445986	238	244	anemia	MESH:D000740
1445986	631	654	extravascular hemolysis	MESH:D006461
1445986	689	705	hemolytic anemia	MESH:D000743
982002	185	204	acute renal failure	MESH:D058186
982002	275	288	renal failure	MESH:D051437
982002	430	442	hemodialysis
982002	876	889	renal lesions	MESH:D001768
343678	62	71	hepatitis	MESH:D006505
343678	154	163	Hepatitis	MESH:D006505
343678	369	378	hepatitis	MESH:D006505
343678	422	440	Clinical hepatitis	MESH:D059466
343678	927	936	Hepatitis	MESH:D006505
343678	1008	1014	type B	MESH:D003057
343678	1134	1145	B hepatitis	MESH:D006509
8888541	0	18	Serotonin syndrome	MESH:D020230
8888541	236	248	hyperthermia	MESH:D005334
8888541	561	579	serotonin syndrome	MESH:D020230
8888541	1404	1431	non-immune thrombocytopenia	MESH:D013921
8888541	1555	1569	rhabdomyolysis	MESH:D012206
8888541	1719	1742	neuromuscular paralysis	MESH:D009468
8106150	50	61	dyskinesias	MESH:D020820
8106150	346	356	dyskinesia	MESH:D020820
8106150	493	513	dyskinetic movements	MESH:D002547
8106150	886	896	dyskinesia	MESH:D020820
21418164	124	170	renal, hepatic and gastrointestinal toxicities	MESH:D056486
21418164	602	628	lymphoma, mast cell tumour	MESH:D008415
21418164	630	642	brain tumour	MESH:D015275
21418164	668	692	epitheliotropic lymphoma	MESH:D008223
21418164	742	753	neutropenia	MESH:D009503
21418164	773	780	anaemia
21418164	803	819	thrombocytopenia	MESH:D013921
21418164	821	847	Gastrointestinal toxicosis	MESH:D005767
21418164	931	955	Potential renal toxicity	MESH:D056486
21418164	1083	1098	hepatic failure	MESH:D017093
9121607	1218	1241	lower relative toxicity	MESH:D056486
9121607	1795	1799	NMDA	MESH:D060426
7905523	909	937	human immunodeficiency virus	MESH:D015658
7905523	939	942	HIV	MESH:D015658
3431591	952	965	breast cancer	MESH:D001943
3431591	967	981	ovarian cancer	MESH:D010051
3431591	983	991	hepatoma	MESH:D006528
3431591	1031	1054	hepatotoxicity, malaise
3431591	1434	1448	nephrotoxicity
3431591	1546	1553	malaise
33969	476	506	increase in tardive dyskinesia	MESH:D009069
16844102	71	84	neurotoxicity	MESH:D020258
16844102	339	342	DFO
16844102	381	394	neurotoxicity	MESH:D020258
16844102	325	337	deferoxamine
16844102	866	878	hyperthermia	MESH:D005334
14633084	73	93	hemorrhagic cystitis	MESH:D003556
14633084	100	120	Hemorrhagic cystitis	MESH:D003556
14633084	122	124	HC
14633084	185	188	IFS	MESH:D049912
14633084	173	183	ifosfamide
14633084	591	599	Cystitis	MESH:D003556
14633084	995	998	IFS	MESH:D049912
11999899	306	325	Parkinson's disease	MESH:D010300
11999899	330	348	tardive dyskinesia	MESH:D009069
11999899	486	506	orofacial dyskinesia	MESH:D009069
11999899	585	603	tardive dyskinesia	MESH:D009069
11999899	835	844	catalepsy	MESH:D002375
11999899	1107	1122	oral dyskinesia	MESH:D009069
11999899	1292	1298	tremor	MESH:D014202
11999899	1754	1794	parkinsonian-like and tardive dsykinesia	MESH:D020734
9431903	283	298	Oddi dyskinesia	MESH:D046628
9431903	758	760	HH	MESH:D006432
9431903	823	826	CBD	OMIM:303800
9431903	1017	1020	CBD	OMIM:303800
9431903	1331	1334	CBD	OMIM:303800
9431903	1825	1840	Oddi dyskinesia	MESH:D046628
8665051	133	141	myopathy	MESH:D009135
8665051	233	241	myopathy	MESH:D009135
8665051	670	693	diaphragm contractility	MESH:D003965
8665051	1442	1472	diaphragmatic type IIa atrophy	MESH:D006938
8665051	1655	1669	muscle atrophy	MESH:D009133
8665051	1887	1934	steroids induced predominantly type IIb atrophy	MESH:D006938
8665051	2064	2075	IIb atrophy	OMIM:606056
7785794	23	53	shock and complete heart block	MESH:C535758
7785794	160	180	complete heart block	MESH:C535758
7785794	334	378	remain hypotensive with complete heart block	MESH:C535758
7785794	596	616	complete heart block	MESH:C535758
8958188	346	353	tumours	MESH:D015275
8958188	951	967	Thrombocytopenia	MESH:D013921
8958188	972	981	mucositis	MESH:D052016
8958188	1564	1570	cancer	MESH:D009369
2557556	581	593	hyperalgesia	MESH:D006930
2557556	775	787	hyperalgesia	MESH:D006930
15580403	56	65	hemolysis	MESH:D006461
15580403	125	142	chronic hepatitis	MESH:D006521
15580403	158	174	Hemolytic anemia	MESH:D000743
15580403	295	311	hemolytic anemia	MESH:D000743
15580403	484	493	hemolysis	MESH:D006461
15580403	657	663	anemia	MESH:D000740
15580403	698	704	anemia	MESH:D000740
15580403	1090	1096	anemia	MESH:D000740
15075188	102	120	nephrotic syndrome	MESH:D009404
15075188	130	148	Nephrotic syndrome	MESH:D009404
15075188	206	211	edema	MESH:D004487
15075188	323	373	epithelial Na channel (ENaC) subunit dysregulation	MESH:D021081
15075188	620	631	proteinuria	MESH:D011507
15075188	633	648	hypoalbuminemia	MESH:D034141
15075188	2062	2080	nephrotic syndrome	MESH:D009404
14745746	42	55	breast cancer	MESH:D001943
14745746	176	189	breast cancer	MESH:D001943
14745746	341	354	breast cancer	MESH:D001943
14745746	385	412	neuropsychological measures
14745746	896	909	breast cancer	MESH:D001943
11208990	80	91	nephropathy	OMIM:161900
11208990	158	160	NO	MESH:D002311
11208990	144	156	nitric oxide	MESH:D028361
11208990	341	359	nephrotic syndrome	MESH:D009404
11208990	670	681	nephropathy	OMIM:161900
11208990	1031	1034	ADR
11208990	1059	1082	mesangial proliferation	MESH:C537346
11208990	1092	1123	tubulointerstitial inflammation	MESH:D007249
11208990	1294	1309	ADR-nephropathy	OMIM:161900
11208990	1425	1440	ADR-nephropathy	OMIM:161900
11208990	1504	1519	ADR-nephropathy	OMIM:161900
11208990	1575	1599	tubulointerstitial areas	MESH:D009395
11208990	1764	1782	renal vascular bed	MESH:D003668
11208990	1983	1992	nephrosis	MESH:D009401
9201797	317	326	catalepsy	MESH:D002375
9201797	458	467	akathisia	MESH:D011595
9201797	895	904	catalepsy	MESH:D002375
9201797	1640	1649	catalepsy	MESH:D002375
8267029	42	60	glomerulonephritis	MESH:D005921
8267029	79	99	rheumatoid arthritis	MESH:D001172
8267029	126	146	rheumatoid arthritis	MESH:D001172
8267029	157	164	rapidly	MESH:C538458
8267029	177	195	glomerulonephritis	MESH:D005921
8267029	298	316	glomerulonephritis	MESH:D005921
8267029	490	501	C3 deposits	OMIM:613779
2528969	460	471	HIV disease	MESH:D015658
2528969	1714	1729	megaloblastosis
384871	16	26	neuropathy	MESH:D003929
384871	235	267	bilateral retrobulbar neuropathy	MESH:D019315
384871	276	321	unusual central bitemporal hemianopic scotoma	MESH:D012607
384871	520	540	optic nerve toxicity	MESH:D056486
133615	50	64	Thromboembolic	MESH:D013923
133615	919	940	myocardial infarction	MESH:D009203
133615	1046	1057	retinopathy	MESH:D003930
133615	1115	1131	thrombophlebitis	MESH:D013924
133615	1189	1205	thrombophlebitis	MESH:D013924
133615	1380	1403	thromboembolic episodes	MESH:D013923
17263743	198	217	decrease heart rate	MESH:D012021
17263743	302	318	seizure disorder	MESH:D004827
17263743	635	662	bradycardia and hypotension	MESH:D001919
17263743	673	694	cardiac resuscitation	MESH:D006331
14982270	20	40	cholestatic jaundice	MESH:D041781
14982270	264	279	hyperthyroidism	MESH:D006980
14982270	499	517	hyperbilirubinemia	MESH:D006932
12911170	22	82	acute interstitial nephritis and autoimmune hemolytic anemia	MESH:D000744
12911170	167	176	nephritis	MESH:D009393
12911170	181	197	hemolytic anemia	MESH:D000743
12911170	315	369	interstitial nephritis and autoimmune hemolytic anemia	MESH:D000744
12911170	371	387	Hemolytic anemia	MESH:D000743
12911170	471	499	acute interstitial nephritis	MESH:D009395
12911170	543	566	end-stage renal disease	MESH:D007676
11195262	329	357	idiopathic generalized tonic	MESH:D004829
11195262	578	616	weakness of the central nervous system	MESH:D002493
10728962	65	85	severe heart failure	MESH:D006333
10728962	172	185	heart failure	MESH:D006333
10728962	277	304	decompensated heart failure	MESH:D006333
7647582	192	220	allergic-type hepatic injury	MESH:D006505
7647582	468	477	hepatitis	MESH:D006505
7647582	1318	1337	halothane hepatitis	MESH:D006505
4090988	28	53	bladder and liver tumours	MESH:D015275
4090988	306	316	neoplastic	MESH:D009386
4090988	665	683	bladder carcinomas	MESH:D001745
4090988	716	731	bladder tumours	MESH:D015275
4090988	860	897	hyperplasia of the bladder epithelium	MESH:D006965
4090988	945	960	bladder calculi	MESH:D001744
4090988	977	984	tumours	MESH:D015275
4038130	404	451	massive degeneration of the extraocular muscles	OMIM:135700
4038130	453	472	Muscle degeneration	MESH:D009135
4038130	639	681	mepivacaine and lidocaine plus epinephrine	MESH:D007625
4038130	740	758	temporary diplopia	MESH:D004172
2907585	321	330	catalepsy	MESH:D002375
2907585	422	431	catalepsy	MESH:D002375
2894433	555	573	reflex bradycardia	MESH:D001919
2894433	631	649	reflex bradycardia	MESH:D001919
2790457	0	21	Chronic carbamazepine	OMIM:608579
2790457	480	491	Chronic CBZ	MESH:D002908
2334179	951	969	nephrotic syndrome	MESH:D009404
2334179	1053	1072	renal insufficiency	MESH:D051437
1969772	827	849	renal vascular effects	MESH:D014652
1700207	67	90	ventricular arrhythmias	MESH:D001145
1700207	185	207	ventricular arrhythmia	MESH:D001145
1700207	216	236	Digitalis arrhythmia	MESH:D001145
1700207	386	407	Adrenaline arrhythmia	MESH:D001145
1700207	583	613	adrenaline-induced arrhythmias	MESH:D001145
1700207	711	741	adrenaline-induced arrhythmias	MESH:D001145
1700207	981	992	arrhythmias	MESH:D001145
1700207	1076	1105	adrenaline-induced arrhythmia	MESH:D001145
19761039	54	69	neurobehavioral	MESH:D019954
19761039	211	231	orofacial dyskinesia	MESH:D009069
19761039	821	824	SOD
19761039	869	872	GSH	OMIM:103900
19761039	799	819	superoxide dismutase
19761039	1165	1185	orofacial dyskinesia	MESH:D009069
11704023	0	21	Comparison of aqueous
11704023	129	137	glaucoma	MESH:D005901
11704023	233	241	glaucoma	MESH:D005901
11704023	628	636	glaucoma	MESH:D005901
11704023	747	755	glaucoma	MESH:D005901
11704023	759	778	ocular hypertension	MESH:D009798
11704023	2100	2108	glaucoma	MESH:D005901
19300240	23	49	apical ballooning syndrome	MESH:D054549
19300240	70	96	apical ballooning syndrome	MESH:D054549
19300240	98	101	ABS
19300240	143	165	acute cardiac syndrome	MESH:D006331
19300240	337	364	epicardial coronary disease	MESH:D003327
19300240	476	479	ABS
19300240	600	617	metastatic cancer	MESH:D009369
19300240	662	670	ischemic	MESH:D002545
19300240	725	749	ST-segment abnormalities	MESH:C535661
19300240	843	860	colorectal cancer	MESH:D015179
19300240	1029	1045	coronary lesions	MESH:D003327
19300240	1295	1301	cancer	MESH:D009369
19300240	1530	1536	cancer	MESH:D009369
19300240	1611	1614	ABS
18006530	1491	1494	TCI
16826348	11	21	neuropathy	MESH:D003929
16826348	91	113	acute myeloid leukemia	MESH:D015470
16826348	357	379	acute myeloid leukemia	MESH:D015470
16826348	795	805	neuropathy	MESH:D003929
16826348	836	846	neuropathy	MESH:D003929
16826348	1123	1133	neuropathy	MESH:D003929
15974569	415	427	hyperalgesia	MESH:D006930
15974569	451	474	mechanical hyperalgesia	MESH:D006930
11583940	336	368	acute and chronic nephrotoxicity	MESH:D000208
11583940	370	390	Acute nephrotoxicity	MESH:D000208
11583940	488	510	chronic nephrotoxicity	MESH:D002908
11583940	548	580	Acute and chronic nephrotoxicity	MESH:D000208
11583940	773	787	nephrotoxicity
11245434	93	99	tumors	MESH:D009369
11245434	152	158	anemia	MESH:D000740
11245434	287	293	tumors	MESH:D009369
11245434	295	301	Anemia	MESH:D000740
11245434	480	486	anemia	MESH:D000740
11245434	646	652	tumors	MESH:D009369
11245434	654	664	DS-sarcoma	MESH:D012509
11245434	776	781	tumor	MESH:D009369
11245434	807	813	tumors	MESH:D009369
11245434	911	923	growth delay	MESH:D006130
11245434	958	964	tumors	MESH:D009369
11245434	986	992	anemia	MESH:D000740
11245434	1124	1130	anemia	MESH:D000740
11245434	1166	1178	growth delay	MESH:D006130
11245434	1287	1293	anemia	MESH:D000740
11245434	1338	1344	tumors	MESH:D009369
11245434	1368	1374	anemia	MESH:D000740
11245434	1491	1496	tumor	MESH:D009369
11243580	174	184	L-arginine	OMIM:612718
11079278	95	114	myocardial ischemia	MESH:D017202
11079278	1493	1512	myocardial ischemia	MESH:D017202
10910842	21	39	muscle dysfunction	MESH:D009135
10910842	1895	1920	neuromuscular dysfunction	MESH:D009468
10910842	1986	2000	muscle atrophy	MESH:D009133
10910842	2267	2281	muscle atrophy	MESH:D009133
10414674	51	61	hemostasis
10414674	79	113	aneurysmal subarachnoid hemorrhage	MESH:D013345
10414674	327	361	aneurysmal subarachnoid hemorrhage	MESH:D013345
10414674	594	608	aneurysmal SAH	MESH:D000783
10414674	1297	1318	intracranial hematoma	MESH:D020198
9523850	49	76	arthralgia-myalgia syndrome	MESH:D018771
9523850	182	213	efficacy of total dose infusion	MESH:C535341
9523850	293	320	arthralgia-myalgia syndrome	MESH:D018771
9523850	1320	1347	arthralgia-myalgia syndrome	MESH:D018771
8384253	341	349	emphasis
8384253	353	364	neuropathic	MESH:D009437
8384253	615	626	neuropathic	MESH:D009437
8384253	1237	1247	neuropathy	MESH:D003929
8268147	10	22	polymyositis	MESH:D017285
8268147	145	167	rheumatologic diseases	MESH:D004194
8268147	218	230	Polymyositis	MESH:D017285
8268147	231	246	dermatomyositis	MESH:D003882
8268147	438	450	polymyositis	MESH:D017285
8268147	644	668	autoimmune complications	MESH:D048909
8268147	674	686	polymyositis	MESH:D017285
8268147	687	702	dermatomyositis	MESH:D003882
8251368	0	57	Photodistributed nifedipine-induced facial telangiectasia	MESH:D013684
8251368	130	168	photodistributed facial telangiectasia	MESH:D013684
8251368	428	456	recurrence of telangiectasia	MESH:D013684
7542793	264	315	degenerative changes of proximal tubular epithelium	MESH:D005198
7542793	369	385	male Wistar rats	MESH:D011906
7542793	438	460	CsA and FK506 toxicity	MESH:D056486
7337133	8	22	cerebral edema	MESH:D001929
7337133	132	146	Cerebral edema	MESH:D001929
7337133	368	382	cerebral edema	MESH:D001929
7337133	430	451	Cranial decompression	MESH:D003665
4069770	11	22	nephropathy	OMIM:161900
4069770	262	268	anuria	MESH:D001002
4069770	567	583	neonatal kidneys	MESH:D007674
3780814	358	361	DEN
3780814	526	529	PAS
3780814	622	625	DEN
3780814	734	745	hepatectomy
3780814	994	999	tumor	MESH:D009369
3780814	1231	1234	DEN
3780697	103	122	respiratory failure	MESH:D012131
3686155	262	271	psychosis	MESH:D011618
3137399	716	731	cardiac failure	MESH:D006333
3137399	789	804	cardiac failure	MESH:D006333
3137399	911	934	clinical cardiotoxicity	MESH:D059466
2709684	18	28	glycosuria	MESH:D006029
2709684	122	139	diabetes mellitus	MESH:D003920
2709684	141	143	DM	MESH:C538008
2709684	303	322	acute renal failure	MESH:D058186
2709684	324	327	ARF
2709684	510	512	DM	MESH:C538008
2709684	528	538	glycosuria	MESH:D006029
2709684	828	836	Group IV	MESH:D003057
2709684	843	845	DM	MESH:C538008
2709684	1125	1142	renal dysfunction	MESH:C535382
458486	220	239	Parkinson's disease	MESH:D010300
458486	458	476	segmental dystonia	MESH:C537538
458486	541	552	dyskinesias	MESH:D020820
21294084	201	204	DBS	MESH:C536390
20727411	40	49	psychosis	MESH:D011618
20727411	191	204	schizophrenia	MESH:D012559
20727411	329	356	psychopathological symptoms	MESH:D009461
20727411	418	431	schizophrenia	MESH:D012559
20727411	515	540	glutamatergic dysfunction	MESH:D018754
20727411	714	718	BOLD
20727411	827	847	verbal fluency tasks	MESH:D013064
20727411	954	984	Positive and Negative Syndrome	MESH:C537591
20727411	1529	1542	schizophrenia	MESH:D012559
20727411	1560	1586	frontal and temporal brain	MESH:C536956
20727411	1657	1682	NMDA receptor dysfunction	MESH:D060426
20727411	1709	1722	schizophrenia	MESH:D012559
20533999	73	86	neurotoxicity	MESH:D020258
20533999	641	657	DA neurotoxicity	MESH:D020258
20533999	770	791	deficient in brain DA	MESH:D001927
20533999	954	971	brain DA deficits	MESH:D009461
20533999	993	1014	dopaminergic deficits	MESH:D009461
20533999	1250	1252	DA
20304337	0	20	Brainstem dysgenesis	MESH:C535397
20304337	246	261	fetal anomalies	MESH:D005315
20304337	342	362	brainstem dysgenesis	MESH:C535397
20103708	54	74	diabetic nephropathy	MESH:D003928
20103708	87	107	Diabetic nephropathy	MESH:D003928
20103708	138	151	renal failure	MESH:D051437
20103708	437	457	diabetic nephropathy	MESH:D003928
20103708	535	555	diabetic nephropathy	MESH:D003928
20103708	595	615	diabetic nephropathy	MESH:D003928
20103708	651	671	diabetic nephropathy	MESH:D003928
20103708	765	785	diabetic nephropathy	MESH:D003928
20103708	949	961	renal damage	MESH:D001925
20103708	1078	1090	renal injury	MESH:D058186
20103708	1227	1247	diabetic nephropathy	MESH:D003928
20103708	1398	1419	renal mesangial cells	MESH:C537346
20103708	1442	1445	ROS
20103708	1805	1825	diabetic nephropathy	MESH:D003928
20103708	1956	1976	diabetic nephropathy	MESH:D003928
19996135	45	56	nonischemic
19996135	1015	1036	ischemic brain injury	MESH:D001930
19996135	1102	1128	neurological abnormalities	MESH:D009422
19674115	0	18	Recurrent dysosmia	MESH:D000857
19674115	90	106	hepatic toxicity	MESH:D056486
19674115	108	121	hyperuricemia	MESH:D033461
19674115	125	144	digestive disorders	MESH:D004828
19674115	300	318	olfactory disorder	MESH:D020431
19674115	484	492	Dysosmia	MESH:D000857
19139001	150	169	colorectal adenomas	OMIM:608456
19139001	225	243	adenomatous polyps	MESH:D018256
19139001	345	367	Temporary hearing loss	MESH:D034381
19139001	406	410	DFMO
19139001	847	851	DFMO
19139001	2014	2018	DFMO
17194457	367	390	parachlorophenylalanine
17194457	1679	1682	AAS	MESH:C535331
16132524	143	165	malignant brain tumors	MESH:D001932
16132524	478	490	glioblastoma	MESH:D005909
16132524	747	759	glioblastoma	MESH:D005909
16132524	994	1005	brain edema	MESH:D001929
16132524	1100	1111	brain edema	MESH:D001929
16132524	1194	1206	glioblastoma	MESH:D005909
12907924	24	53	obsessive-compulsive symptoms	MESH:D009771
12907924	394	423	obsessive-compulsive disorder	MESH:D009771
12139551	128	142	cardiac arrest	MESH:D006323
12139551	731	738	cardiac	MESH:D006331
10411803	0	30	Severe immune hemolytic anemia	MESH:D000743
10411803	249	265	hemolytic anemia	MESH:D000743
10411803	323	340	hemolytic anemias	MESH:D000743
10411803	468	498	severe immune hemolytic anemia	MESH:D000743
10225068	0	21	Cauda equina syndrome	MESH:D011128
10225068	28	46	spinal anaesthesia	MESH:D013122
10225068	103	124	cauda equina syndrome	MESH:D011128
10225068	198	219	cauda equina syndrome	MESH:D011128
10225068	883	904	neurological deficits	MESH:D009461
9549528	75	95	peak-dose dyskinesia	MESH:D020820
9549528	373	383	dyskinesia	MESH:D020820
9549528	421	441	peak-dose dyskinesia	MESH:D020820
9549528	582	605	dyskinetic parkinsonian	MESH:D020734
9549528	928	970	hyperkinetic abnormal involuntary movement	MESH:D020820
9549528	997	1012	dose dyskinesia	MESH:D020820
7843916	170	193	corticosteroid glaucoma	MESH:D005901
7843916	483	517	donor eyes from regional eye banks	MESH:D005128
7843916	594	605	Paired eyes	MESH:D005128
7843916	1369	1386	hypertensive eyes	MESH:D006973
7843916	1782	1796	untreated eyes	MESH:D005128
7843916	2165	2188	corticosteroid glaucoma	MESH:D005901
7843916	2198	2212	angle glaucoma	MESH:D005902
7843916	2309	2325	steroid glaucoma	MESH:D005901
7843916	2343	2357	angle glaucoma	MESH:D005902
7803371	99	101	DM	MESH:C538008
7803371	81	97	Dextromethorphan
7803371	512	531	acute toxic effects	MESH:D056486
7803371	568	576	insomnia	MESH:D007319
7803371	578	584	ataxia	MESH:D001259
7803371	921	923	DM	MESH:C538008
7803371	1109	1111	DM	MESH:C538008
6496797	0	20	Complete heart block	MESH:C535758
6496797	146	166	complete heart block	MESH:C535758
6496797	257	275	cardiac conduction	OMIM:115080
3411101	41	60	fulminant hepatitis	MESH:D017114
3411101	161	180	fulminant hepatitis	MESH:D017114
3411101	504	523	fulminant hepatitis	MESH:D017114
2598570	24	49	acute flank pain syndrome	MESH:D021501
2598570	212	237	acute flank pain syndrome	MESH:D021501
2598570	418	446	epidemiology of the syndrome	MESH:D013577
2598570	769	775	asthma	MESH:D001249
2598570	1167	1180	renal disease	MESH:D052177
2598570	1492	1508	unusual syndrome	MESH:C537916
1415380	0	25	Hemolytic-uremic syndrome	MESH:D006463
1415380	64	89	Hemolytic-uremic syndrome	MESH:D006463
1415380	487	501	renal function	OMIM:608852
1415380	641	666	hemolytic-uremic syndrome	MESH:D006463
1255900	103	126	pyeloureteritis cystica	MESH:D016137
1255900	155	189	chronic infection and inflammation	MESH:D007249
1255900	278	307	pyeloureteral filling defects	MESH:D000013
1255900	515	538	pelvic thrombophlebitis	MESH:D013924
1255900	692	707	pyeloureteritis
1255900	720	741	submucosal hemorrhage	MESH:D006470
85485	50	58	hepatoma	MESH:D006528
85485	121	130	hepatomas	MESH:D006528
85485	135	175	hyperplastic preneoplastic liver lesions	MESH:D011230
85485	311	320	hepatomas	MESH:D006528
85485	346	352	tumors	MESH:D009369
85485	409	414	tumor	MESH:D009369
85485	554	566	hyperplastic	MESH:D000796
85485	947	964	process hepatomas	MESH:D006528
48362	0	19	Quinidine hepatitis	MESH:D006505
48362	206	222	active hepatitis	MESH:D006521
9067481	425	427	CS	MESH:D006223
9067481	501	503	CS	MESH:D006223
9067481	1391	1393	CS	MESH:D006223
9067481	1559	1587	galactosamine hepatotoxicity	MESH:D009085
19274460	166	173	myeloma	MESH:D009101
19274460	406	422	multiple myeloma	MESH:D009101
19274460	424	426	MM
19274460	977	996	progressive disease	MESH:D018450
19274460	1054	1081	gastrointestinal toxicities	MESH:D056486
19274460	1093	1103	neuropathy	MESH:D003929
18201582	251	272	stage II hypertension	MESH:D006973
18201582	512	533	stage II hypertension	MESH:D006973
18201582	709	730	stage II hypertension	MESH:D006973
18201582	962	974	diastolic BP	MESH:D006337
18201582	976	979	DBP	MESH:C536663
18201582	1642	1645	DBP	MESH:C536663
18201582	1928	1944	Peripheral edema	MESH:D004487
18201582	2253	2261	diarrhea	MESH:D003967
11337188	0	37	Cutaneous leucocytoclastic vasculitis	MESH:D018366
11337188	153	170	aureus bacteremia	MESH:D016470
11337188	182	195	renal failure	MESH:D051437
11337188	348	375	leucocytoclastic vasculitis	MESH:D014657
11337188	433	448	corticosteroids	OMIM:611489
11337188	493	507	renal function	OMIM:608852
11337188	528	555	Leucocytoclastic vasculitis	MESH:D014657
11337188	647	657	arthralgia	MESH:D018771
11337188	663	680	renal involvement	OMIM:248190
11337188	757	782	collagen vascular disease	MESH:D003095
11337188	787	796	neoplasia	OMIM:274230
11337188	879	900	self-limited disorder	MESH:C536711
11337188	1115	1142	leucocytoclastic vasculitis	MESH:D014657
6308526	33	63	cardiorespiratory, temperature	MESH:D000377
6308526	373	384	hypothermia	MESH:D007035
6308526	597	608	bradycardia	MESH:D001919
15897593	318	355	myelosuppression and cardiac toxicity	MESH:D056486
15897593	434	470	anthracycline-induced cardiotoxicity	MESH:D020751
15897593	1957	1977	hematologic toxicity	MESH:D056486
6817363	414	435	sublethal hypercapnia	MESH:D006935
6817363	806	823	retrieval-deficit	MESH:D009461
11900788	42	51	catalepsy	MESH:D002375
11900788	828	849	cholinergic receptors	MESH:C535672
11230490	0	22	Reduced cardiotoxicity	MESH:D006987
11230490	212	236	metastatic breast cancer	MESH:D001943
11230490	525	549	metastatic breast cancer	MESH:D001943
11230490	551	554	MBC
11230490	618	621	MBC
11230490	652	670	metastatic disease	MESH:C538219
11230490	1031	1055	congestive heart failure	MESH:D006333
11230490	1057	1060	CHF
11230490	1108	1113	tumor	MESH:D009369
11230490	1226	1228	MC
11230490	1274	1277	CHF
11230490	1282	1284	AC	MESH:D055577
11230490	1468	1470	MC
11230490	1510	1521	neutropenia	MESH:D009503
11230490	1523	1557	Antitumor efficacy of MC versus AC	MESH:D055577
11230490	1885	1896	neutropenia	MESH:D009503
2594614	104	130	cardiovascular impairments	MESH:D002318
2594614	845	847	HR
2594614	1246	1289	bupivacaine-induced cardiovascular toxicity	MESH:D056486
2257294	93	135	anti-human immunodeficiency virus activity	MESH:D015658
2257294	348	380	antihuman immunodeficiency virus	MESH:D014777
2257294	549	555	anemia	MESH:D000740
2257294	560	570	leukopenia	MESH:D007970
2257294	751	757	anemic
2257294	935	953	AZT-induced anemia	MESH:D000740
2257294	958	968	leukopenia	MESH:D007970
2257294	1101	1116	megaloblastosis
10840460	25	33	cystitis	MESH:D003556
10840460	220	222	CP	MESH:D002547
10840460	360	368	cystitis	MESH:D003556
10840460	202	218	Cyclophosphamide
10840460	1598	1630	chorionic and muscle layer edema	MESH:D004487
10840460	2182	2190	cystitis	MESH:D003556
8278214	0	12	Hyperalgesia	MESH:D006930
8278214	30	45	terminal cancer	MESH:D009369
8278214	101	113	Eight cancer	MESH:D009369
8278214	219	231	hyperalgesia	MESH:D006930
8278214	342	364	universal hyperalgesia	MESH:D006930
8278214	369	382	hyperesthesia	MESH:D006941
8278214	633	645	hyperalgesia	MESH:D006930
8278214	646	655	myoclonus	MESH:D009207
8278214	824	844	behavioural syndrome	MESH:D013577
3934126	422	438	thrombophlebitis	MESH:D013924
3934126	581	597	Thrombophlebitis	MESH:D013924
3934126	655	685	nephrotoxicity and ototoxicity	OMIM:580000
3934126	725	755	aminoglycoside plus vancomycin	OMIM:580000
1687392	59	68	catalepsy	MESH:D002375
1687392	314	323	catalepsy	MESH:D002375
19719056	251	253	ED	MESH:C536181
19719056	222	249	etodolac-dextran conjugates	MESH:D009759
19719056	789	791	ED	MESH:C536181
19719056	925	927	ED	MESH:C536181
15266362	0	28	Hypersensitivity myocarditis	MESH:D009205
15266362	42	69	hypertrophic cardiomyopathy	MESH:D002312
15266362	116	140	eosinophilic myocarditis	MESH:D009205
15266362	154	181	hypertrophic cardiomyopathy	MESH:D002312
15266362	229	256	hypertrophic cardiomyopathy	MESH:D002312
15266362	276	297	biventricular failure	MESH:D051437
15266362	467	490	ventricular dysfunction	MESH:D018754
15266362	604	631	hypertrophic cardiomyopathy	MESH:D002312
15266362	636	647	myocarditis	MESH:D009205
15266362	699	723	eosinophilic myocarditis	MESH:D009205
15266362	844	868	Eosinophilic myocarditis	MESH:D009205
14648024	33	41	erythema	MESH:D004890
14648024	67	95	acute promyelocytic leukemia	MESH:D015473
14648024	166	194	acute promyelocytic leukemia	MESH:D015473
14648024	196	199	APL	OMIM:209500
14648024	272	280	erythema	MESH:D004890
14648024	517	525	erythema	MESH:D004890
14648024	766	774	erythema	MESH:D004890
14648024	860	868	erythema	MESH:D004890
11827497	0	46	Delayed-onset heparin-induced thrombocytopenia	MESH:D013921
11827497	76	92	thrombocytopenia	MESH:D013921
11827497	155	187	arterial or venous thromboemboli	MESH:D014647
11827497	226	258	heparin-induced thrombocytopenia	MESH:D013921
11827497	421	437	thrombocytopenia	MESH:D013921
11827497	642	658	thrombocytopenia	MESH:D013921
11827497	797	812	thromboembolism	MESH:D013923
11827497	1748	1766	inferior vena cava	MESH:D013479
11827497	1893	1909	thrombocytopenia	MESH:D013921
11827497	2015	2031	thrombocytopenia	MESH:D013921
11827497	2086	2101	thromboembolism	MESH:D013923
8841157	64	86	essential hypertension	OMIM:145500
8841157	1417	1422	edema	MESH:D004487
2576810	416	429	hyperactivity	MESH:D006948
20635749	7	31	congestive heart failure	MESH:D006333
20635749	70	84	myxedemic coma	MESH:D003128
20635749	126	139	myxedema coma	MESH:D009230
20635749	172	186	hypothyroidism	MESH:D007037
20635749	212	236	congestive heart failure	MESH:D006333
20635749	238	241	CHF
20635749	324	337	myxedema coma	MESH:D009230
20635749	375	388	Myxedema coma	MESH:D009230
20635749	597	600	CHF
20635749	663	677	hypothyroidism	MESH:D007037
20635749	750	753	TSH	OMIM:275100
20635749	721	748	thyroid stimulating hormone	OMIM:275100
20635749	867	870	CHF
20635749	917	930	myxedema coma	MESH:D009230
20635749	1029	1032	CHF
20635749	1071	1109	weakness or other unexplained symptoms	MESH:D018908
20394767	154	157	LES
20394767	121	152	light-enhanced startle paradigm	MESH:C537693
20394767	291	294	FPS
20394767	265	289	fear-potentiated startle	MESH:C537693
20394767	498	501	FPS
20394767	964	967	LES
20394767	971	974	FPS
20394767	1051	1054	FPS
20394767	1231	1234	FPS
20394767	1278	1281	FPS
20394767	1327	1330	FPS
20394767	1473	1476	FPS
19203554	81	99	glomerulonephritis	MESH:D005921
19203554	168	186	ulcerative colitis	MESH:D003093
19203554	197	205	red eyes	MESH:D005128
19203554	225	237	eosinophilia	MESH:D004802
19203554	242	263	urinary abnormalities	MESH:C536480
19203554	377	395	glomerulonephritis	MESH:D005921
19203554	404	432	deposition of immunoglobulin	MESH:C536290
19203554	1237	1255	glomerulonephritis	MESH:D005921
17049862	79	98	Chiari malformation	MESH:C531625
17049862	200	217	myelomeningocoele
17049862	458	482	acute severe bradycardia	MESH:D001919
17049862	527	582	cardiac depressant actions of phenytoin and hypothermia	MESH:D007035
17049862	647	658	hypothermia	MESH:D007035
16225977	70	83	Tic disorders	MESH:D013981
16225977	413	437	involuntary eye-blinking	MESH:D020820
12852481	0	49	Comparison of developmental toxicology of aspirin	MESH:D055963
12852481	236	259	developmental anomalies	OMIM:607932
12852481	468	479	Wistar rats	MESH:D011906
12852481	500	502	GD	MESH:D005776
12852481	529	538	Wilson JG	MESH:D006527
12852481	483	498	gestational day	MESH:D016640
12852481	748	750	SD	MESH:D029461
12852481	915	917	SD	MESH:D029461
12852481	956	990	maternal gastrointestinal toxicity	MESH:D056486
12852481	1051	1054	ASA	MESH:D056807
12852481	732	746	Sprague-Dawley
12852481	1333	1335	SD	MESH:D029461
12852481	1474	1500	ventricular septal defects	MESH:D006345
12852481	1512	1527	midline defects	MESH:C536633
12852481	1546	1566	diaphragmatic hernia	MESH:D006548
12852481	1568	1570	DH
12852481	1502	1506	VSDs
12852481	1529	1532	MDs
12852481	1770	1772	DH
12852481	1774	1776	MD	MESH:C535955
12852481	1782	1785	VSD	MESH:D004310
12852481	1816	1819	VSD	MESH:D004310
12852481	1885	1887	MD	MESH:C535955
12852481	1966	1969	VSD	MESH:D004310
12852481	2037	2066	major developmental anomalies	MESH:D004830
12852481	2075	2093	Wistar and SD rats	MESH:D029461
12852481	2127	2130	VSD	MESH:D004310
12852481	2138	2140	SD	MESH:D029461
12852481	2150	2163	hydrocephalus	MESH:D006849
12852481	2171	2182	Wistar rats	MESH:D011906
11858397	164	189	acquired long QT syndrome	MESH:D008133
11009181	138	157	Parkinson's disease	MESH:D010300
11009181	590	598	levodopa
11009181	1265	1276	dyskinesias	MESH:D020820
11009181	1353	1375	cutaneous tolerability	OMIM:301220
11009181	1542	1561	Parkinson's disease	MESH:D010300
8988571	729	741	hyperthermia	MESH:D005334
8988571	1141	1153	sudden death	MESH:D003645
6615052	16	32	thrombocytopenia	MESH:D013921
6615052	34	44	thrombosis	MESH:D013927
6615052	104	120	thrombocytopenia	MESH:D013921
6615052	555	599	hemorrhagic and thromboembolic complications	MESH:D013923
3952818	111	126	colon carcinoma	MESH:D003108
3084782	44	64	rheumatoid arthritis	MESH:D001172
3084782	135	155	rheumatoid arthritis	MESH:D001172
3084782	157	159	RA	MESH:D001172
3084782	363	372	nephritis	MESH:D009393
3084782	377	387	dermatitis	MESH:D003872
3084782	408	437	D-Penicillamine like compound	MESH:D005597
3084782	473	491	between dermatitis	MESH:D003872
3084782	607	609	RA	MESH:D001172
3084782	643	652	nephritis	MESH:D009393
430165	47	73	diphenylhydantoin toxicity	MESH:D056486
430165	227	249	cerebellar dysfunction	MESH:D002526
430165	410	413	DPH	OMIM:222748
16600756	292	295	OAB
16600756	753	756	OAB
16600756	859	862	OAB
16600756	972	975	OAB
16600756	1207	1210	OAB
16600756	1280	1283	OAB
15686794	181	200	atrial fibrillation	MESH:D001281
15686794	202	204	AF
15686794	300	319	atrial fibrillation	MESH:D001281
12760988	155	162	myalgia	MESH:D011000
12760988	378	385	myalgia	MESH:D011000
12760988	417	451	succinylcholine-associated myalgia	MESH:C535825
12760988	704	711	myalgia	MESH:D011000
12760988	770	777	myalgia	MESH:D011000
12760988	1003	1025	marker of inflammation	MESH:D005600
12760988	1176	1183	myalgia	MESH:D011000
12760988	1209	1216	myalgia	MESH:D011000
12760988	1319	1353	succinylcholine-associated myalgia	MESH:C535825
12760988	1489	1534	succinylcholine-induced postoperative myalgia	MESH:C535825
12691807	17	39	oromandibular dystonia	MESH:D008538
12691807	75	103	Levodopa-induced dyskinesias	MESH:D004409
12691807	126	173	Parkinson's disease and multiple system atrophy	MESH:D019578
12691807	175	192	Cranial dystonias	MESH:D004421
12691807	251	254	PSP	MESH:D013494
12691807	219	249	progressive supranuclear palsy	MESH:D013494
12691807	331	353	Oromandibular dystonia	MESH:D008538
12691807	355	358	OMD	OMIM:613587
11860495	1344	1349	PREGS
11860495	1765	1770	PREGS
11752998	588	632	capsaicin-evoked mechanical hypersensitivity	MESH:D006967
11752998	1071	1094	mechanical hyperalgesia	MESH:D006930
11752998	1099	1108	allodynia	MESH:D006930
11752998	1278	1301	mechanical hyperalgesia	MESH:D006930
11752998	1306	1315	allodynia	MESH:D006930
10354657	366	381	thyroid disease	MESH:D013959
10354657	547	563	bipolar disorder	MESH:D001714
10354657	959	973	Hypothyroidism	MESH:D007037
10354657	1151	1165	hypothyroidism	MESH:D007037
10354657	1356	1370	hypothyroidism	MESH:D007037
10354657	1723	1747	Familial thyroid illness	MESH:D005067
10354657	1769	1783	hypothyroidism	MESH:D007037
10354657	1788	1801	hypercalcemia	MESH:D006934
10328196	81	90	psoriasis	MESH:D011565
10328196	107	130	capillary leak syndrome	MESH:D019559
10328196	309	318	psoriasis	MESH:D011565
10328196	331	354	capillary leak syndrome	MESH:D019559
10328196	571	594	capillary leak syndrome	MESH:D019559
10328196	791	800	psoriasis	MESH:D011565
10328196	999	1004	fever	MESH:D005334
10328196	1006	1012	anemia	MESH:D000740
10328196	1018	1041	capillary leak syndrome	MESH:D019559
10328196	1239	1248	psoriasis	MESH:D011565
10328196	1261	1275	capillary leak	MESH:D019559
10328196	1360	1381	inflammatory diseases	MESH:D009220
8480959	68	88	hypercholesterolemia	MESH:D006937
8480959	174	194	hypercholesterolemia	MESH:D006937
8480959	1525	1533	Myopathy	MESH:D009135
8480959	1929	1957	primary hypercholesterolemia	MESH:D006937
7197363	155	159	REMD
7197363	132	153	REM sleep deprivation	MESH:D012892
7197363	278	282	REMD
7197363	374	378	REMD
7197363	420	424	REMD
7161250	162	165	EPS	MESH:C538012
7161250	133	160	extrapyramidal side effects	MESH:D001480
7161250	771	774	EPS	MESH:C538012
7053705	8	30	veno-occlusive disease	MESH:D011668
7053705	150	176	acute lymphocytic leukemia	MESH:D054198
7053705	558	580	veno-occlusive disease	MESH:D011668
6402369	138	160	inoperable lung cancer	MESH:D008175
6402369	280	299	urothelial toxicity	MESH:D056486
6402369	369	391	inoperable lung cancer	MESH:D008175
6402369	753	763	haematuria
6402369	783	799	gross haematuria	MESH:C536704
6402369	1200	1216	gross haematuria	MESH:C536704
6402369	1236	1254	bladder irritation	MESH:D054971
6402369	1256	1264	cystitis	MESH:D003556
6402369	1269	1281	pollakisuria
6402369	1410	1473	haematological or systemic toxicity of the cytostatic treatment	MESH:D056486
3973521	109	132	ventricular angiography	MESH:D018754
3461217	14	43	autochthonous prostate cancer	MESH:D011471
3461217	47	60	Lobund-Wistar
3461217	143	156	Lobund-Wistar
3461217	192	225	palpable prostate adenocarcinomas	MESH:D000230
3461217	282	285	CAS	OMIM:602081
3461217	362	380	tumor-bearing rats	MESH:D011906
3461217	392	410	metastatic lesions	MESH:C538219
3461217	158	161	L-W	MESH:C538106
3461217	550	552	TP
3461217	581	586	tumor	MESH:D009369
3461217	650	665	prostate cancer	MESH:D011471
2840807	0	24	A dystonia-like syndrome	MESH:D004421
2840807	98	115	movement disorder	MESH:D009069
2840807	185	204	idiopathic dystonia	MESH:D020821
2840807	900	917	movement disorder	MESH:D009069
2840807	1034	1065	unilateral cerebellar fastigial	MESH:D002526
2569282	180	185	D-MED	MESH:C536739
2569282	210	227	muscle flaccidity	MESH:D009123
2569282	163	178	dexmedetomidine
2343592	181	194	renal disease	MESH:D052177
2055425	128	145	diabetes mellitus	MESH:D003920
1711760	43	66	focal cerebral ischemia	MESH:D002545
1711760	78	89	brain edema	MESH:D001929
1711760	165	197	middle cerebral artery occlusion	MESH:D020244
1711760	208	229	brain edema formation	MESH:D001929
1711760	199	203	MCAO
1711760	415	418	MAP	MESH:C535477
1711760	391	413	mean arterial pressure	MESH:D003668
1711760	684	692	ischemia	MESH:D007511
1711760	1102	1125	less edema accumulation	MESH:D004487
1711760	1626	1646	neuronal dysfunction	MESH:D009410
1595783	0	29	Amiodarone pulmonary toxicity	MESH:D056486
1595783	147	164	being pneumonitis	MESH:D011014
1595783	321	349	hypersensitivity pneumonitis	MESH:D000542
1595783	529	542	heart failure	MESH:D006333
804391	89	101	tuberculosis	MESH:D014376
804391	148	160	tuberculosis	MESH:D014376
804391	418	430	tuberculosis	MESH:D014376
804391	550	555	PHA-P	MESH:D010381
804391	593	604	tuberculous	MESH:D014390
28952	27	39	hypokalaemia
28952	47	76	chlorthalidone administration
28952	94	116	essential hypertension	OMIM:145500
28952	224	236	hypokalaemia
28952	383	395	hypokalaemia
28952	1413	1449	renin-angiotensin-aldosterone system	MESH:D006929
28952	1480	1500	distal renal tubules	MESH:D007673
19893084	36	55	acute renal failure	MESH:D058186
19893084	97	116	acute renal failure	MESH:D058186
18513945	64	84	neuraxial anesthesia	MESH:C535694
18513945	320	348	systemic vascular resistance	MESH:D057772
18513945	804	832	systemic vascular resistance	MESH:D057772
18513945	1027	1047	neuraxial anesthesia	MESH:C535694
18513945	1119	1147	systemic vascular resistance	MESH:D057772
18513945	1194	1204	heart rate	MESH:D006331
18513945	1348	1368	neuraxial anesthesia	MESH:C535694
18483878	145	153	cystitis	MESH:D003556
18483878	190	193	VIP	MESH:D003969
18483878	155	188	Vasoactive intestinal polypeptide	MESH:D003969
18483878	405	413	cystitis	MESH:D003556
18483878	487	490	VIP	MESH:D003969
18483878	563	571	cystitis	MESH:D003556
18483878	694	727	bladder of wild type (WT) and VIP	MESH:C536751
18483878	766	774	cystitis	MESH:D003556
18483878	921	942	WT control versus VIP	MESH:C536751
18483878	961	963	WT	MESH:C536751
18483878	1390	1403	bladder of WT	MESH:C536751
18483878	1566	1584	WT urinary bladder	MESH:D001745
18483878	1656	1676	bladder inflammation	MESH:D007249
18483878	1746	1749	CYP
18483878	1801	1820	bladder dysfunction	MESH:D001750
18483878	1843	1863	bladder inflammation	MESH:D007249
17923537	800	814	implanted eyes	MESH:D005128
17923537	916	930	implanted eyes	MESH:D005128
15096016	107	126	Parkinson's disease	MESH:D010300
15096016	128	130	PD	OMIM:168600
15096016	161	187	posteroventral pallidotomy
15096016	367	392	ventrolateral thalamotomy
15096016	666	668	PD	OMIM:168600
15096016	678	689	dyskinesias	MESH:D020820
15096016	918	929	dyskinesias	MESH:D020820
15096016	990	1012	dyskinetic upper limbs	MESH:D002547
12734532	58	79	myocardial infarction	MESH:D009203
12734532	245	290	hypertensive episodes and hemorrhagic strokes	MESH:D020521
12734532	359	376	myocardial injury	MESH:D009202
12734532	472	489	myocardial injury	MESH:D009202
12734532	621	638	myocardial injury	MESH:D009202
12013711	41	60	visual disturbances	MESH:D012640
12013711	64	77	schizophrenic	MESH:D012559
12013711	110	113	LSD
12013711	176	179	LSD
12013711	219	222	EPS	MESH:C538012
12013711	343	362	visual disturbances	MESH:D012640
12013711	457	476	visual disturbances	MESH:D012640
12013711	533	536	LSD
12013711	599	618	visual disturbances	MESH:D012640
12013711	703	722	visual disturbances	MESH:D012640
11861791	72	105	doxorubicin-induced heart failure	MESH:D006333
11861791	430	439	antitumor
11861791	766	785	cardiac dysfunction	MESH:D006331
11861791	1167	1186	cardiac dysfunction	MESH:D006331
11861791	1470	1473	DOX
11302406	162	165	TDP	MESH:D057177
11302406	95	113	torsade de pointes	MESH:D016171
11302406	212	228	Candida glabrata	MESH:C536777
11302406	273	276	TDP	MESH:D057177
11302406	379	402	coronary artery disease	MESH:D003324
11302406	404	418	cardiomyopathy	MESH:D009202
11302406	420	444	congestive heart failure	MESH:D006333
11302406	647	681	premature ventricular contractions	MESH:D018879
11302406	686	722	nonsustained ventricular tachycardia	MESH:D017180
11302406	903	906	TDP	MESH:D057177
11302406	724	728	NSVT
11302406	1422	1425	TDP	MESH:D057177
11302406	1549	1572	ventricular arrhythmias	MESH:D001145
11058428	293	322	acute corticosteroid myopathy	OMIM:611489
11058428	589	607	spinal cord injury	MESH:D013119
11058428	627	643	steroid myopathy	MESH:D009135
11058428	780	796	steroid myopathy	MESH:D009135
11058428	1017	1046	acute corticosteroid myopathy	OMIM:611489
11022397	1215	1224	eye drops	MESH:D013575
10692744	22	40	Gerstmann syndrome	MESH:D005862
10692744	138	154	renal impairment	MESH:C536274
10692744	198	216	Gerstmann syndrome	MESH:D005862
10565806	0	23	Hypomania-like syndrome	MESH:C536855
10565806	120	138	psychotic disorder	MESH:D011618
10565806	162	171	hypomania
9061311	72	91	acute liver failure	MESH:D017114
9061311	191	211	bacterial infections	MESH:D001424
9061311	229	248	acute liver failure	MESH:D017114
9061311	250	253	ALF
9061311	321	324	ALF
9061311	419	422	ALF
9061311	506	509	ALF
9061311	630	633	ALF
9061311	934	937	ALF
9061311	1054	1057	ALF
9061311	1161	1164	ALF
8494478	22	36	nephrotoxicity
8494478	54	60	cancer	MESH:D009369
8494478	139	145	cancer	MESH:D009369
8494478	160	179	acute renal failure	MESH:D058186
8494478	476	485	nephritis	MESH:D009393
8494478	793	812	acute renal failure	MESH:D058186
8475949	29	64	polymorphic ventricular tachycardia	MESH:C536334
8475949	125	153	ventricular tachyarrhythmias	MESH:D013610
8475949	361	375	hypomagnesemia	MESH:C537153
7710775	78	106	incomplete cerebral ischemia	MESH:D002545
7710775	119	147	Incomplete cerebral ischemia	MESH:D002545
7710775	385	393	ischemia	MESH:D007511
7710775	579	587	ischemia	MESH:D007511
7710775	802	810	ischemia	MESH:D007511
7710775	917	949	Increased plasma malondialdehyde	MESH:D054219
7710775	1151	1159	ischemia	MESH:D007511
7710775	1301	1309	ischemia	MESH:D007511
7710775	1578	1586	ischemic	MESH:D002545
7650771	0	20	Cholinergic toxicity	MESH:D056486
7650771	73	89	iodide eye drops	MESH:D013575
7650771	120	140	cholinergic syndrome	MESH:C535672
7650771	220	235	muscle weakness	MESH:D018908
7650771	277	294	myasthenia gravis	MESH:D009157
7650771	413	445	discontinuation of the eye drops	MESH:D013575
7565311	6	19	renal failure	MESH:D051437
7565311	98	117	acute renal failure	MESH:D058186
7565311	248	299	metastatic parameningeal embryonal rhabdomyosarcoma	MESH:D018233
7565311	307	320	renal failure	MESH:D051437
7421734	0	21	Endometrial carcinoma	MESH:D016889
7421734	28	43	Hodgkin disease	MESH:D006689
7421734	99	120	endometrial carcinoma	MESH:D016889
7421734	127	142	Hodgkin disease	MESH:D006689
7421734	165	180	ovarian failure	OMIM:300510
7421734	230	245	Hodgkin disease	MESH:D006689
7421734	326	344	endometrial cancer	MESH:D016889
7421734	348	364	menopausal women	MESH:D008594
7421734	407	435	ovarian failure after cancer	MESH:D010051
7421734	476	497	endometrial carcinoma	MESH:D016889
6732043	29	49	sleep apnea syndrome	MESH:D012891
6732043	241	274	physical changes and the syndrome	MESH:D059445
6732043	973	993	sleep apnea syndrome	MESH:D012891
6454943	64	75	proteinuria	MESH:D011507
6454943	79	110	spontaneously hypertensive rats	MESH:D011906
6454943	230	247	renal abnormality	MESH:D002869
6454943	479	490	proteinuria	MESH:D011507
3120485	93	114	lumbar epidural block	MESH:D015174
2886572	75	92	hypertensive rats	MESH:D011906
1079693	25	54	juvenile rheumatoid arthritis	MESH:D001171
1079693	81	110	juvenile rheumatoid arthritis	MESH:D001171
1079693	186	199	iridocyclitis	MESH:D015863
1079693	201	214	Iridocyclitis	MESH:D015863
1079693	333	342	arthritis	MESH:D001168
1079693	383	390	uveitis	MESH:D014605
1079693	667	674	uveitis	MESH:D014605
1079693	977	1007	corticosteroids and mydriatics	OMIM:611489
1079693	1137	1145	Cataract	MESH:D002386
1079693	1155	1166	keratopathy
1079693	1312	1329	chorioretinopathy	MESH:C537711
1079693	1455	1486	posterior subcapsular cataracts	MESH:C535339
1079693	1498	1526	Typical keratoconjunctivitis	MESH:D007637
1079693	1559	1566	uveitis	MESH:D014605
1079693	1596	1603	uveitis	MESH:D014605
1079693	1660	1669	cataracts	MESH:D002386
1079693	1671	1687	band keratopathy	MESH:D000652
1079693	1693	1701	glaucoma	MESH:D005901
803783	576	607	asthenia, muscular irritability	MESH:D001247
